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ABSTRACT
THE ROLE OF GLYCOCONJUGATES IN MEDIATING HUMAN 
SPERM-EGG BINDING AND IN THE INDUCTION OF FETO- 
MATERNAL TOLERANCE
Manish Suresh Patankar 
Old Dominion University and Eastern Virginia Medical School, 1998 
Director: Dr. Gary F. Clark
Using the hemizona assay (HZA), a in vitro sperm-egg binding assay, we show 
that specific glycoconjugates known to inhibit immune cell interactions mediated by the 
selectins, potently block human sperm-egg binding. The selectin ligand sialyl Lewis* 
inhibits sperm binding in the HZA by 60% at a concentration of 1 mg/ml. Our data 
indicates that glycodelin-A, a endometrial glycoprotein known to block sperm-egg binding 
in the HZA at low concentrations expresses unusual fiicosylated lacdiNAc type glycans. 
The fiicosylated lacdiNAc type sugars have been previously shown to be 15-20 fold more 
potent ligands of E-selectin. Glycodelin-S a seminal plasma glycoform of glycodelin-A 
does not express such unusual glycans and is not contraceptive. These results support our 
hypothesis that human sperm-egg binding may involve a selectin-like event.
Periodate oxidation under conditions that affect only the terminal sugar residues 
results in a 30-40% loss in sperm binding. Treatment of the ZP with neuraminidase and 
endo-P-galactosidase results in a 2.5 and 4 fold enhancement in sperm binding 
respectively. However, sequential treatment of the ZP with neuraminidase and periodate 
results in 80% decrease in sperm binding. These studies strongly indicate that ZP glycans 
are essential for mediating human gamete binding. Furthermore, efficient initial human
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
sperm egg binding in vivo may require a prior activation event involving desialylation of 
the gametes.
In this study we provide preliminary evidence that human gametes express the 
bisecting type glycans. Our studies indicate that these glycans potently inhibit natural killer 
(NK) cells, the predominant cell type expressed in the uterus during pregnancy. Other 
glycoconjugates like a-fetoprotein, expressed in the uterus during pregnancy, also carry 
the bisecting-type glycans. Based on these observations we propose that glycoconjugates 
expressed during pregnancy protect are responsible for mediating feto-matemal tolerance. 
We refer to this model for as the Human Feto-Embryonic Defense System hypothesis. 
Finally our data suggests that parasites like schistosomes, filarial worms, and the human 
immunodeficiency virus may be evading the host’s immune responses by a similar by 
expressing immunosuppressive glycoconjugates on their coats.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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1CHAPTER I 
INTRODUCTION
Review o f the Literature
Carbohydrates constitute a major component of the diverse biopolymers expressed 
in both the animal and the plant kingdom. These sugar chains are either found as free 
oligosaccharides or may be attached to lipid (glycolipids) or protein (glycoproteins) 
backbones. Such oligosaccharide bearing chimeric molecules are referred to as 
glycoconjugates. The main purpose of this research is to examine the role of carbohydrates 
in mediating human fertilization and human pregnancy. A brief review of the chemistry and 
biochemistry and the possible biological roles of carbohydrates in mammals are provided to 
acquaint the reader with the various aspects of carbohydrate biology (commonly referred to 
as glycobiology) and to review the latest developments in this field.
Biosynthesis o f Oligosaccharides
The most common type of monosaccharides found in mammals are L-fucose (Fuc), 
D-glucose (Glc), D-galactose (Gal), D-mannose (Man), D-A-acetylglucosamine (GlcNAc), 
D-A’-acetylgalactosamine (GalNAc), and A-acetylneuraminic acid (NeuAc; also known as 
sialic acid) (Figure 1). These sugars are linked to each other via (9-glycosidic bonds to form 
the oligosaccharides. Synthesis of the oligosaccharide chains of glycolipids or glycoproteins 
is initiated in the endoplasmic reticulum of the cell and is completed in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 1: Structures of monosaccharides commonly found in mammalian glycans. The 
names and abbreviations commonly used for these sugars are given.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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4the irons compartment of the Golgi apparatus. Two components that are absolutely 
essential for the synthesis of oligosaccharide chains are the glycosyltransferases and the 
sugar nucleotides. Glycosyltransferases are enzymes that catalyze the addition of the 
monosaccharide units to the growing oligosaccharide chain (Paulson and Colley, 1988). 
For this reaction the glycosyltransferases require sugar nucleotides as the source for the 
monosaccharide units. Sugar nucleotides carry a monosaccharide attached to the nucleotide 
via a high energy phosphate bond. The energy required for the addition of the 
monosaccharide to the oligosaccharide chain is provided by the hydrolysis of this high 
energy bond. The nucleotide sugars used as substrates by the different types of 
glycosyltransferases are listed in Table 1.
Many different types of glycosyltransferases have been identified and characterized 
to date (Paulson and Colley, 1988). The glycosyltransferases are named according to the 
monosaccharide that they add to the oligosaccharide chain that is being synthesized. Thus 
enzymes that add Gal to the growing sugar chain are termed as the galactosyltransferases 
(Gal-T), whereas those adding a GlcNAc residue are iV-acetylglucosaminyltransferases 
(GlcNAc-T). Glycosyltransferases are further classified according to the linkage position to 
which the monosaccharide unit is being added. For example, a fucosyltransferase (Fuc-T) 
that adds a Fuc residue to the oligosaccharide in the a l-3  position is termed as the al-3 
Fuc-T, whereas the enzyme that adds a Fuc in the a  1-2 linkage is referred as the a  1-2 Fuc- 
T. Approximately 100 or more different glycosyltransferases are required for the synthesis 
of all of the known carbohydrate structures on glycolipids and glycoproteins (Paulson and 
Colley, 1988). Table 2 shows the commonly found glycosyltransferases that
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1: Nucleotide sugars used as donor substrates by different glycosyltransferases.
Glycosyltransferase Nucleotide Sugar Substrate (Abbreviation)
Glucosyltransferases Uridine diphosphoglucose (UDP-GIc)
Galactosyltransferases Uridine diphosphogalactose (UDP-Gal)





Fucosyltransferases Guanidine diphosphofiicose (GDP-Fuc)
Sialyltransferases Cytidine monophosphoneuraminic acid
(CMP-NeuAC)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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7are required for the synthesis of the terminal sugars. The sequence specificities o f the 
glycosyltransferases are also shown.
Different Types o f Mammalian Glycoconjugates
(a) Glycoproteins
Oligosaccharides conjugated to the protein backbone are of two major types, the N- 
linked and the CMinked oligosaccharides (Komfeld and Komfeld, 1985; Olofsson, 1991) . 
The AMinked oligosaccharides are attached to the protein via an asparagine (Asn) residue 
whereas the O-linked chains are conjugated via serine (Ser) or threonine (Thr) residues of 
the protein. The Asn residue o f a protein flanked by an -X-Ser/Thr (where X is any amino 
acid) sequence is usually a good consensus site for A-glycosylation (Komfeld and Komfeld, 
1985). However, not all Asn residues in this Asn-X-Ser/Thr motif are TV-glycosylated. No 
consensus sequence has been shown to exist for the O-glycosylation sites. The typical 
structures of the N- and CMinked oligosaccharides are shown in Figure 2.
Biosynthesis of the 0-linked chain is initiated by the addition of a GalNAc to the 
Ser or Thr residue of the protein (Olofsson, 1991). This reaction is followed by the 
sequential addition of the other monosaccharide units by the appropriate 
glycosyltransferases. Recently however, an unusual modification of some proteins has been 
reported where Ser or Thr residues are modified by a single GlcNAc. The (3-linked 
carbohydrate chains may range in size from one to more than 20 sugars with the larger 
oligosaccharides displaying considerable structural and antigenic diversity (Olofsson, 
1991). Typically the CMinked oligosaccharides are expressed in clusters o f heavily
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 2: Structures o f some of the commonly found iV-linked and 0-linked glycans in 
mammals. Structures shown in Panel A-C are complex type, hybrid type, and high 
mannose type A'-Iinked sugars. Panel D and E show structures of CMinked glycans found 
on erythrocyte surface glycoproteins.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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glycosylated domains of the protein. Mucins are a classic example of proteins carrying 
heavily (9-glycosylated domains. Two O-linked oligosaccharides expressed on human 
erythrocyte membrane glycoproteins are shown in Figure 2.
N-linked oligosaccharides are broadly classified into the complex type, hybrid, and 
high mannose type structures (Figure 2). The basic core of Ar-linked oligosaccharide is 
initially synthesized on a lipid named dolichol (Komfeld and Komfeld, 1985). The core 
structure is then transferred en block to the Asn residue of the protein by a specific 
oligosaccharidyl transferase enzyme. The core structure is further modified by addition and 
deletion of specific monosaccharide units in the endoplasmic reticulum and Golgi 
apparatus, to produce the final structures shown in Figure 2.
(b) Glycolipids:
Glycolipids are synthesized by the sequential addition of the sugars to a lipid core. 
Glycolipids are typically found in animal cells have a sphingosine backbone. These 
glycolipids are referred to as the glycosphingolipids (GSL) (Basu and Basu, 1982). The 
GSL are widely distributed in animal tissues, particularly the synaptic membranes and cell 
surfaces. Most commonly occurring GSL’s can be classified into two different families (a) 
the acidic or NeuAc containing GSL’s also known as gangliosides, and (b) the neutral 
GSL’s containing mono-, di-, or oligoglycosyl chains attached to the ceramide backbone. 
Gangliosides may contain one or more NeuAc residues. The neutral polyglycosyl GSL’s 
are further subdivided into two classes, (a) the blood group active GSL’s which contain a 
core structure of GlcNAcpi-3Gaipi-4Glcpi-lCeramide, and (b) the globosides whose 
core structure is Galal-4Gaipi-4GlcP 1-1 Ceramide (Table 3). Many of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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glycosyltransferases that are involved in the synthesis of glycoprotein glycans are also used 
for GSL oligosaccharide synthesis.
Glycoforms
The final products of glycosylation linked to a single protein are very diverse. 
Studies indicate that a significant number of the molecules of a glycoprotein may not have 
the fully formed oligosaccharide chain. For example porcine fibrinogen carries two different 
forms of oligosaccharides (Figure 3) (Da Silva et al., 1994). A single glycoprotein is 
homogenous in its protein component but usually heterogeneous in its carbohydrate 
sequences. A subset of glycoprotein molecules that are homogeneous in both their protein 
and carbohydrate sequences is referred to as a glycoform. Therefore a single glycoprotein 
generally consists of a mixture of different glycoforms (Rademacher et al., 1988). 
Biological Roles fo r Oligosaccharides
In recent times, considerable effort has been devoted to understanding the chemistry 
and biochemistry of glycoconjugates. However, determining the exact physiological roles 
of these molecules has remained enigmatic. Carbohydrates have been conventionally known 
to affect the three dimensional structure of proteins (Varki, 1993). Therefore glycans have 
been postulated to play a major role in determining the folding patterns of proteins. It has 
been reported recently that simple occupation of key glycosylation sites may be the critical 
factor regulating protein folding in certain cases (Helenius, 1994; Allen et al., 1995; Feng et 
al., 1995). For example, occupancy of crucial N-linked glycosylation sites by a single 
monosaccharide (GlcNAc-Asn) is sufficient to allow proper folding of rat leutenizing 
hormone receptor to occur (Zhang et al., 1995).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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NeuAca2-6-Gal-P 1 -4GlcNAcP 1  -2 Mana 1  - /  Fucal - 6
Figure 3: Two different glycans found on porcine fibrinogen.
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Another proposed role for carbohydrates is that, being hydrophilic molecules, they 
help solubilize the proteins better in the intercellular and intracellular milieu (Varld, 1993). 
While this proposed function may be a valid biological role for the carbohydrates, it is 
difficult to understand the expression of structural diversity of the oligosaccharides in this 
context. For example, if the sole purpose of expressing carbohydrates on proteins or lipids 
was to increase the solubility of these molecules, it would have been more beneficial for the 
cell to express only a few particular kinds of carbohydrate structures that could help 
solubilization of the molecules. However, oligosaccharide structures reported so far in the 
literature are extremely diverse. Furthermore, there have also been reports of the 
oligosaccharides being modified by acetyl, glycolyl, sulfate, or phosphate groups (Varki, 
1992; Komfeld et al., 1982). Thus each individual cell expends considerable effort in the 
synthesis of the oligosaccharide structures, sugar nucleotides, and various enzymes like 
glycosyitransferases and glycosidases involved in the synthesis and the degradation of 
carbohydrates. It is in fact believed that an individual mammalian cell spends as much as 30 
% of its total energy reserve on the synthesis of the oligosaccharides chains.
Few examples are available in the literature that conclusively demonstrate the 
importance of carbohydrates in mediating any cellular event. Several studies implicating the 
lack of oligosaccharide production or specific defects in the oligosaccharide processing 
enzymes in various disease states have been reported. Examples of two such diseases are 
discussed below to illustrate this point.
Carbohydrate-deficient glycoprotein syndrome (CDGS) is a family of multisystemic 
congenital diseases which are caused due to the underglycosylation of glycoproteins. The 
exact biochemical defect responsible for causing this disease has not been pinpointed.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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However, recent data suggests an abnormality in one of the steps of glycan assembly on the 
protein (Charuk et al., 1993). Interestingly, one of the variants of CDGS (designated 
CDGS II) has been linked to the deficiency of the GlcNAc-T II (Table 2), an enzyme 
required for the synthesis of iV-linked oligosaccharides. Individuals suffering from CDGS 
exhibit severe neurological and physical defects (Charuk, et al., 1993).
Tay-Sachs disease is another prominent example of the link between a deficiency of 
a proper oligosaccharide processing enzyme and a disease state. Tay-Sachs disease is an 
autosomal recessive disorder caused by inadequate activity of the enzyme (3-N- 
acetylhexosaminidase, used for degrading gangliosides in the brain. Gangliosides are found 
in the highest concentration in the nervous system and are continually degraded by the 
action of glycosidases, like P-N-acetylhexosaminidase (Mahuran, 1995). Deficiency of this 
enzyme results in the accumulation of the gangliosides in the brain of the infant suffering 
from Tay-Sachs disease, resulting in severely retarded psychomotor development, impaired 
vision and spasticity. Tay-Sachs disease is fatal usually before the infant is three years of 
age.
However, such physiological disorders associated with either the lack of or 
incorrect expression or degradation of the oligosaccharide sequences do not provide 
evidence for the functional role for carbohydrates in cellular events. It can still be argued 
that the reason for these disorders is due to incorrect folding of the proteins that bear the 
aberrant oligosaccharides thereby inducing them to be inactive or to mediate abnormal 
functions.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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The Selectins
In recent years more evidence has been presented suggesting a direct physiological 
role for oligosaccharides in mediating many cellular events. Recruitment of the leukocytes 
to the sites of inflammation has to occur under the influence of extremely high shear forces 
generated by the high bulk rate of flow of the blood cells in the postcapillary venules 
(Lasky, 1995). However, such high shear forces do not prevent the tight binding of 
leukocytes to the inflamed endothelium. The tight binding of these inflammatory cells has 
been shown to be mediated by the cell adhesion molecules known as integrins. The slow 
rolling of leukocytes on the surface of the inflamed endothelium occurs due to binding of 
three specific carbohydrate binding proteins expressed on the surface of the leukocytes and 
endothelial cells, with their respective ligands. These three receptors, E-, L-, and P- 
selectins have been identified and very well characterized (Lasky, 1995). E-selectin has 
been found to be primarily expressed on the inflamed endothelium. P-selectin is expressed 
in the a -  granules of the platelets and the Wiebel-Palade bodies of the endothelial cells. 
This selectin is rapidly translocated to the cell surface during inflammation. L-Selectin is 
expressed on various leukocytes.
All three selectins carry a C-type lectin domain that can bind to a specific 
carbohydrate ligand in the presence o f calcium (Lasky, 1995). The expression of the three 
selectins is also differentially regulated. L-Selectin is constitutively expressed on the surface 
of the myeloid leukocytes and is rapidly shed by proteolytic cleavage after leukocyte 
activation where it helps in mediating adhesion to high endothelial venules of peripheral 
lymph nodes and to cytokine activated endothelial cells (Lasky, 1995). E-selectin is 
synthesized by endothelial cells after stimulation with cytokines. Expression of E-selectin
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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peaks 4 hours after stimulation and returns to basal levels within 12-24 hours. P-selectin is 
rapidly translocated to the cell surface upon activation by agonists such as thrombin or 
histamine. At the cell surface P-selectin serves as a receptor for the myeloid cells and 
subsets of lymphocytes.
Considerable effort has been made to identify the exact ligand recognized by the 
three selectins (Varki, 1994). Sialyl Lewisx (NeuAca2-3Gaipi-4[Fucal-3]GlcNAc), a 
tetrasaccharide expressed on many glycoproteins and glycolipids has been shown to be a 
ligand for the three selectins. Evidence supporting the role of sialyl Lewisx in mediating 
adhesion include:
(1) Antibodies directed against sialyl Lewisx blocked cell adhesion mediated by both E- 
and P-selectins (Walz, et al., 1990; Phillips, et al., 1990; Polley, et al., 1991),
(2) Liposomes containing glycolipids carrying the sialyl Lewisx epitope blocked 
leukocyte adhesions to the inflamed endothelium (Lasky, 1995)
(3) All three selectins bind with differing affinities to immobilized glycolipids bearing 
the sialyl Lewisx terminated glycans (Foxall, et al., 1992)
Substantial evidence suggests that sialyl Lewisx is a low affinity ligand for these 
selectin molecules (Varki, 1994). Oligosaccharides bearing the sulfo-Lewisx (S03 '-3Gaipi- 
4[Fucal-3]GlcNAc-) and sulfo-Lewis* (S03‘-3Gaipi-3[Fucal-4 ]GlcNAc-) sequences on 
their terminal ends also serve as ligands for the selectins. Other high affinity ligands have 
since been identified. These high affinity ligands carry clusters of highly sialylated or 
sulfated oligosaccharides which are responsible for serving as ligands for the selectins. In 
addition to the presence of C-type lectin domain all of the three selectins also express a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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epidermal growth factor-like domain (Lasky, 1995). It is therefore likely that recognition of 
the oligosaccharide ligand by the selectins could trigger a signal transduction cascade 
through the epidermal growth factor-like domain. Such signaling events could in turn allow 
tight binding of the lymphocytes to the inflamed endothelium via other receptors such as 
the integrins.
The selectins have also proved to be excellent candidates for devising strategies for 
the prevention of reperfusion injuries most commonly seen in patients with ischemia 
(McEver, 1995). Efforts are under way to use sialyl Lewisx as a therapeutic agent for 
blocking the recruitment of the leukocytes to the ischemic tissue thereby preventing these 
injuries.
Other Mammalian Lectins
In addition to the selectins, a growing number of studies have indicated the 
presence of other mammalian lectins on the surfaces of various immune effector cells and 
also on neural cells (Varki, 1992). Recently, many different C-type and I-type lectins have 
also been shown to be expressed on different immune cell types. I-Type lectins are specific 
for sialic acids (Powell and Varki, 1995). CD22 is an example of an I-type lectin that is 
expressed on the naive B-cells. Absence of CD22 on the naive B-cells results in 
hyperactivation of the cells, suggesting that this molecule could play an important role in 
the maturation process of the B-cells (O’Keefe, 1997). Recent reports suggest that the 
ligand for CD22 is terminal NeuAca2-6Gaipi-4GlcNAc. Similarly, many C-type lectins 
like CD94, and NKR-P1A have been shown to be expressed on natural killer cells and 
various other T-cell subsets (Moretta et al., 1997).
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The exact physiological roles of many of these mammalian lectin receptors are 
currently under intense scrutiny. However, the diversity of the different oligosaccharide 
chains expressed by the mammalian cells and the presence of specific carbohydrate binding 
proteins strongly suggests that carbohydrates may be playing significant roles in various 
physiological events. Research efforts currently undertaken by several groups in various 
aspects of mammalian glycobiology will definitely help to determine the exact roles of the 
glycoconjugates.
Role o f Carbohydrates in Reproduction
Another critical biological process that has been proposed to be mediated via 
glycoconjugates is the initial binding of the male and female gametes (Bedford, 1977). 
Studies performed in many different species throughout the animal kingdom have indicated 
that specific carbohydrates expressed on the surface of the egg are recognized as ligands 
for specific egg binding protein(s) expressed on the plasma membrane of the sperm. 
Considerable evidence obtained by investigators using the murine model system also 
strongly suggests the involvement of the carbohydrates in mediating mammalian sperm-egg 
interaction (Wassarman, 1990). Mammalian eggs are surrounded by an extracellular matrix 
referred to as the zona pellucida (ZP). During fertilization, sperm initially bind the ZP 
before penetrating into the ooplasm. In the mouse, the ZP is primarily composed of three 
glycoproteins, ZP1, ZP2 and ZP3 (Wassarman, 1988). Wassarman and co-workers have 
demonstrated that carbohydrate chains expressed on ZP3 play a major role in mediating 
murine sperm-ZP binding (Wassarman et al., 1986). Initial studies indicate that human 
sperm-ZP binding is also mediated by the ZP glycans (Wassarman, 1990). However, 
conclusive proof of the involvement of glycoconjugates in mediating human gamete binding
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has been lacking until recently. Initial studies performed by our group strongly suggested 
that specific carbohydrate ligands could potently inhibit human sperm-egg binding (Mahony 
et al., 1991; Oehninger et al., 1991; Patankar et al., 1993). These studies, reviewed in depth 
in the introduction section of Chapter II, further indicate that the carbohydrate ligands 
responsible for mediating human sperm-egg binding may also overlap with the same ligands 
mediating human immune cell interactions (Patankar, et al., 1993). The purpose of the 
current study was therefore to further investigate the validity of these initial observations 
made in our laboratory.
Specific Aims o f this Study
(1) To conclusively determine if human sperm-egg binding is a carbohydrate mediated 
event.
(2) To demonstrate the expression of carbohydrate sequences that could possibly play a 
role in mediating immune cell interactions on the surface of the human gametes.
(3) To demonstrate that carbohydrate sequences expressed on the surface of the 
gametes could affect immune cell function.




Fertilization of the female gamete is the first committed step in reproduction. 
Mammalian fertilization is a multi-step process initiated by the binding of sperm to the egg. 
This initial binding event results in fusion and subsequent transmission of genetic material 
from parents to the offspring. Research performed using the mouse as the animal model 
system has been helpful in providing considerable insights in the initial events leading to 
fertilization. The understanding gained from these experiments and their impact on the 
human gamete binding system is reviewed here.
Events Leading to Fertilization in Mice
The mammalian egg is surrounded by an extracellular matrix known as the zona 
pellucida (ZP) (Figure 4). The sperm initially undergo loose attachment to the ZP. This 
initial loose attachment is followed by a tight binding of the sperm to ZP. Tight adhesion of 
the gametes is supposed to be mediated by the binding to the receptor expressed on the 
surface of the sperm head to the ligands expressed on the ZP (Wassarman, 1990) (Figure 
4). Lying beneath the surface of the sperm is an organelle referred to as the acrosome 
(Figure 4). The acrosome is a lysosome-like body which contains proteases and 
glycosidases. The tight binding of the sperm to the ZP results in fusion of the plasma 
membrane with the outer acrosomal membrane, blebbing off of the fused membrane and 
exposure of the inner acrosomal membrane (McLeskey et al., 1998). This process of fusion
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Figure 4: Mammalian gametes and major events occurring during fertilization. Panels A 
and B show the important structural features of the sperm and the egg respectively. The 
initial loose binding followed by tight adhesion and the penetration o f the sperm into the 
egg is shown in Panel B.
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of the acrosomal membrane followed by the release of the acrosomal contents is known as 
the acrosomal reaction. Proteases released in this step help the sperm to penetrate through 
the ZP and reach the perivitelline space present between the ZP and the egg (Figure 4). 
Once the sperm reach the perivitelline space, the plasma membranes of the gametes fuse 
together to form the zygote.
Initial Sperm-ZP Binding
Considerable advances have been made in understanding the initial binding of 
mouse sperm to the ZP. As discussed earlier the tight binding of the sperm to the ZP is 
absolutely essential for the future events of fertilization to occur. A similarity between the 
binding of leukocytes of inflamed endothelium and sperm-ZP binding is the presence of 
high shear forces. Murine ZP3 has been isolated and purified from oocytes. Electrophoretic 
studies indicate that this glycoprotein migrates as a diffuse band with an apparent molecular 
weight of approximately 83 (kDa) (Wassarman, 1988). ZP3 has also been shown to be 
sulfated and migrates on isoelectric focusing gels with an average pi of 4.7 (Shimizu et al.,
1983). Amino acid analysis of the ZP3 polypeptide chain indicates that it is composed of 
402 amino acids with a calculated molecular weight of 44 kDa (Wassarman, 1988). ZP3 
expresses 3-4 //-linked oligosaccharide chains and an undetermined number of O-linked 
oligosaccharide chains (Salzmann et al., 1983). It has been accepted that the heterogeneous 
nature of ZP3 observed during electrophoretic analysis of this glycoprotein is primarily due 
to the posttranslational modification of this protein and not because of any heterogeneous 
nature of the polypeptide chain.
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Several lines o f evidence have been presented suggesting that ZP3 mediates binding 
o f sperm to the ZP:
(1) Initially it was observed that ZP3 purified form mouse oocytes bound specifically to 
the sperm head and not the midpiece or the tail (Bleil and Wassarman, 1986). This 
finding is consistent with the fact that only the head of the sperm is capable of 
undergoing tight binding with the ZP
(2) Purified murine ZP3 does not bind to acrosome reacted murine sperm (Bleil and 
Wassarman, 1986). This observation complements the data that the acrosome reaction 
of the sperm is preceded by the tight binding of the gametes
(3) Purified ZP3 inhibits murine sperm-ZP binding at relatively low concentrations 
(Florman and Wassarman, 1985) (Bleil and Wassarman, 1980) (Florman et al., 1984)
(4) Perhaps the most conclusive data demonstrating ZP3 as the primary receptor for the 
sperm was obtained when it was shown that acrosome intact mouse sperm tightly 
bound to silica beads coated with murine ZP3 (Vazquez et al., 1989)
(5) ZP3 was also shown to be capable of inducing acrosome reaction in murine sperm, 
albeit at high concentrations (Bleil and Wassarman, 1983) (Florman, Bechtol et al.,
1984)
(6) ZP3 purified from mouse embryos did not bind to the heads of the mouse sperm 
(Bleil and Wassarman, 1986). This observation is consistent with the fact that mouse 
sperm do not undergo any attachment with the embryo. Thus considerable evidence has 
been accumulated so far suggesting that at least in the murine model, sperm bind to the 
ZP viaZP3.
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ZP3 Oligosaccharides Mediate Sperm Binding
As mentioned earlier, murine ZP3 has been shown to be heavily glycosylated. It was 
initially reported that exposure of ZP3 to high temperatures (100°C), or to denaturants like 
urea and detergents like sodium dodecyl sulfate (SDS) did not significantly affect its ability 
to serve as a sperm receptor (Bliel and Wassarman, 1980, Wassarman, 1985; Wassarman, 
1989). Exposure to such harsh conditions usually results in denaturation o f proteins, in 
turn resulting in the loss of their biological activities. Carbohydrates have however been 
shown to be very resistant to such denaturing conditions. Therefore these initial 
observations indicated that the oligosaccharide chains expressed on ZP3 could be playing a 
role in mediating sperm-ZP binding. This suggestion perfectly complemented prior 
observations that various monosaccharides, glycoconjugates, and lectins were capable of 
abrogating the binding of the sperm to the ZP in the murine system in vitro (Huang et al., 
1982; Shur and Hall, 1982) (Oikawa et al., 1973) (Ahuja, 1982; Ahuja, 1985) (Shur and 
Hall, 1982) (Lambert, 1984). It was further observed that some of the ZP3 glycopeptides 
obtained upon digestion of the glycoprotein with pronase retained the ability to serve as 
sperm receptor, although they were unable to induce acrosome reaction in the sperm 
(Florman, Bechtol et al., 1984). More recently it was shown that the (9-linked and not the 
//'-linked ZP3 oligosaccharides were absolutely essential for this molecule to serve as the 
mouse sperm receptor (Litscher and Wassarman, 1996).
Further studies performed by Wassarman and co-workers indicated that a-linked 
galactose at the nonreducing terminal of a subpopulation of the O-linked ZP3 
oligosaccharides was absolutely essential for murine sperm-ZP binding (Wassarman, 1990). 
Removal of this a-galactose by the enzyme a-galactosidase or by oxidation of the C-6
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alcohol of this sugar to an aldehyde by galactose oxidase resulted in complete abrogation of 
the sperm-receptor function of this oligosaccharide (Bleil and Wassarman, 1988). Recently 
it has been shown that a synthetic oligosaccharide bearing a  1-3 linked galactose terminals 
could effectively block binding of the murine sperm to the ZP (Litscher et al., 1995). Thus 
there is considerable evidence to suggest that the oligosaccharides expressed on the murine 
ZP3 are responsible for mediating sperm-ZP binding.
ZP3 is Found in A ll Mammalian Species
Studies performed to date have indicated that all mammalian species carry a 
homolog of murine ZP3. ZP3 from many different species including the human have been 
cloned and expressed in different cell types. The presence of ZP3 in all the mammalian 
species indicates that the role of this molecule, i.e. in mediating sperm-ZP binding may have 
been conserved in all of these species.
Human ZP3
As mentioned above, the human homolog of murine ZP3 has been cloned and 
isolated. Based on the evidence obtained in the mouse system, it has been suggested that 
the human ZP3 also may be playing a major role in mediating binding of sperm to the ZP. 
However, the lack of significant number of human eggs has severely curtailed the ability to 
isolate human ZP3 and to directly assess its potential as a sperm receptor as performed in 
the mouse studies. To circumvent this problem, many researchers have attempted to obtain 
recombinant human ZP3 (Chapman and Barratt, 1996). However, to date, a totally 
biologically active ZP3 molecule has not been produced. It has been shown that 
glycoproteins obtained using recombinant DNA technologies do not express the same
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biological activities, or at least not with the same potency. For example appropriate 
expression of the glycan chains is absolutely essential for producing biologically active 
glycohormones like leutenizing hormones (Thotakura and Blithe, 1995).
Different cell types probably follow a specific program for glycosylation. The 
differences in the glycosylation patterns within cell types is apparent considering the 
various types o f glycosyltransferases and the cell surface carbohydrates expressed by these 
cells. For example, the Chinese hamster ovary cell line that is often used to obtain 
recombinant proteins predominantly expresses high mannose type oligosaccharides on its 
cell surface. Therefore the proteins being transfected in this cell line often also end up 
expressing high mannose type oligosaccharide structures. Thus if the expression of 
specific type(s) of oligosaccharide(s) is required, it is very likely that the recombinant 
protein would not exhibit the correct biological activity unless it was transfected in the right 
cell type. A similar situation may be occurring with human recombinant ZP3. Human ZP3 
is expressed by the egg cells and therefore may probably have to be expressed in a very 
specific cell line to obtain biologically active recombinant human ZP3. The inability to 
obtain a biologically active recombinant ZP3 molecule indirectly suggests that its 
oligosaccharides may be playing an important role in mediating sperm receptor function.
Using the Hemizona Assay to Determine the Role o f Oligosaccharides in Human Sperm- 
ZP Binding
The inability to directly assess the role of the ZP3 oligosaccharides in mediating 
human sperm-ZP binding due to reasons specified above have therefore forced 
investigators to search for other alternative strategies to study this interaction at the 
molecular level. However, even for such indirect methods, the main challenge has been the
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availability of human eggs in significant numbers. Furthermore, incubation of live human 
eggs with sperm could potentially result in the formation of human embryos, thus leading to 
severe ethical dilemmas. To circumvent these problems, the hemizona assay was developed 
(Burkman et al., 1988). The initial use of the hemizona assay was restricted to assessing 
sperm dysfunction in male patients (Burkman, Coddington et al., 1988). The general 
paradigm for conducting this assay is provided in Figure 5. In the first step, human eggs are 
microbisected in to two equal halves. The halves are aspirated vigorously to expel the 
cellular egg contents, leaving behind the two equal halves of the ZP known as hemizona. Of 
these two hemizonae, one is used as a control and the other as the test (Figure 5). In the 
clinical application, the control hemizona is incubated with sperm from normal known 
fertile donor whereas the test hemizona is exposed to sperm obtained from the patient. The 
incubation is carried out for 4 hours in an 5% CO2 incubator. The individual hemizona are 
then washed thoroughly in media to remove any loosely bound sperm. The sperm that are 
tightly bound to each hemizona are counted. Comparison of the number of sperm bound to 
the test versus the control hemizona is done to assess the dysfunction of the sperm from the 
patient. The comparison is done by calculating the hemizona index (HZI) as follows-
HZI= (Number of sperm Bound to the test Hemizona)/(Number of sperm bound to control 
hemizona) X 100.
An HZI of 100 indicates no difference in the binding capacity of the sperm from the 
patient. Complete sperm dysfunction is reflected if the HZI is 0.
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Figure 5: Schematic diagram of the modified hemizona assay (HZA) to test the effect of 
different substances on human sperm-ZP binding. The human eggs are initially bisected 
and the zona pellucida is isolated from the ooplasm. The test hemizona is incubated with 
the sperm in the presence of the test substance and the control is incubated with sperm in 
the presence of PBS (or any other suitable placebo substance). The number of sperm 
bound to the hemizona after 4 h incubation are counted and the hemizona index (HZI) is 
calculated as shown.








Incubate for 4 h
Control
Hemizona
Number of Sperm Bound to Test Hemizona ^  jqq
Number of Sperm Bound to Control Hemizona
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
32
The main advantage of the HZA is that it provides an internally controlled test as 
the matched hemizonae are derived by microbisection of the same egg (Burkman, 
Coddington et al., 1988). The use of the same egg as the control and test also is beneficial 
in reducing the number of eggs required to do such studies. Considering these advantages, 
the HZA was modified to perform various studies to assess the role o f different chemical 
and biochemical agents to affect human sperm-ZP binding (Oehninger et al., 1990). The 
test hemizona was incubated with sperm from healthy proven fertile donor (defined as a 
donor who has fathered a child in the past two years), in the presence o f the test substance 
and the control hemizona was incubated with the sperm from the same donor in the 
absence of the test substance (Figure 5). The HZI is calculated by counting the number of 
sperm bound to the test versus the control. The HZI indicates if the test substance had any 
effect on human sperm-ZP binding as discussed above. The inhibitory effect of the test 
substance in the HZI is calculated by the formula-% inhibition in the HZA = (100 - HZI).
A number of different substances were initially screened in the HZA for their effect 
on sperm-ZP binding (Oehninger, et al., 1990). It was hypothesized that the test substance 
that could potently inhibit sperm binding in the HZA would at least be mimicking the 
natural ligands expressed on the surface of the zona. The identification o f such a substance 
could therefore provide valuable insights about the molecular mechanisms involved in 
mediating this adhesive event.
Fucoidcm, a Potent Inhibitor o f Sperm Binding in the HZA
Studies on mouse sperm-ZP binding had already indicated that the oligosaccharide 
chains attached to the ZP could be playing an important role in this event. Therefore,
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initially Oehninger and co-workers, tested different glycoconjugates for their ability to 
inhibit in the HZA (Mahony, et al., 1991; Oehninger, et al., 1991). Of all the 
glycoconjugates tested at that time, fucoidan, an algal polysaccharide primarily composed 
of Fuc and sulfate, was found to be an extremely potent inhibitor of human sperm-ZP 
binding in the HZA (Mahony, et al., 1991). Incubation of the test hemizona with the sperm 
in the presence of 50 |ig/ml of fucoidan resulted in 80% inhibition of binding as compared 
to the matched control. Other sulfated polysaccharides like dextran sulfate, chondroitin 
sulfate did not have any effect on this interaction in the HZA (Oehninger, et al., 1991). 
Furthermore it was found that neither Fuc nor sodium sulfate had any major effect on the 
binding (Oehninger, et al., 1991). These control experiments therefore indicated that 
fucoidan was specifically able to block sperm-ZP binding in the HZA.
Previously, Huang et al., (1982) had reported that fucoidan could block sperm-ZP 
binding in humans. They also reported that fucoidan was also a potent inhibitor of sperm- 
ZP binding in other mammalian species (Huang and Yanagimachi, 1984). For example 
fucoidan could block the sperm binding in the mouse and the guinea pig system. However, 
the action of fucoidan in these lower mammalian species was significantly different than 
that observed in humans. In the lower mammals when sperm binding assays were 
conducted in the presence of fucoidan, the sperm could undergo initial tight binding to the 
ZP but would then eventually fall off (Huang and Yanagimachi, 1984). In humans however, 
short term incubation (0.25-0.5 h) of fucoidan potently inhibited the initial binding 
interaction (Huang et al., 1982; Clark and Oehninger, unpublished observations). Thus in 
the lower mammalian species, fucoidan inhibited the secondary binding interaction whereas, 
in humans the initial or primary binding was inhibited by this algal polysaccharide.
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Reevaluation o f the Structure o f Fucoidan
Other than demonstrating that an algal polysaccharide like fucoidan could inhibit human 
sperm-ZP binding, these studies also indicated that similar to the mouse system, specific 
glycoconjugates could be playing a major role in mediating human sperm-ZP binding. To 
understand the molecular basis of the inhibition of fucoidan we undertook a study to 
characterize the structure of this polysaccharide. The structure of fucoidan was first studied 
in the 1950’s using the technology available at that time (Percival, 1967) (Figure 6). With 
the availability of modem structural analysis tools like gas chromatography-mass 
spectroscopy (GC-MS), a more sensitive and critical analysis o f the structure was 
performed (Patankar, Oehninger et al., 1993). Our analysis indicated that contrary to the 
findings of the early studies, the structure of fucoidan showed substantial differences when 
analyzed by GC-MS. Previous studies performed by Percival et al (1967) indicated that 
fucoidan was primarily a polymer of a  1-2 linked Fuc with relatively small number of 
branches of Fuc extending from the core in a l-4  linkages (Figure 6). A majority of the 
sulfates were shown to be present on the 4- position hydroxyl group. Our studies indicated 
that the core structure of fucoidan is composed of a  1-3-linked Fuc chain that is highly 
branched with a  1-2 and a l-4  fiicose units attached to the a  1-3 linked core structure 
(Patankar, et al., 1993). This work constituted the major analysis completed for the 
fulfillment of the Masters thesis of this candidate. Comparison between the previous and 
the new model obtained for fucoidan are shown in Figure 6.
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Figure 6: The new average structure of fucoidan. Panel A  and B show the previously 
reported structure of this polysaccharide (Percival et al., 1967). The new average structure 
reported for fucoidan is shown in Panel C.
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Fucoidan also Inhibits Selectin Mediated Events
In addition to its ability to block mammalian sperm-ZP binding fucoidan was also 
shown to be a very potent inhibitor of L-selectin mediated attachment of the leukocytes to 
the inflamed endothelium (Foxall et al., 1992). As mentioned earlier, sulfo-Lewisx and 
sulfo-Lewis* terminated glycans are potent ligands for the selectins (Varki, 1994; (Yuen, et 
al., 1992; Green, et al., 1992). Sulfo-Lewisx carries a a  1-3 linked Fuc and the sulfo-Lewisa 
structure has a a  1-4 linked Fuc attached to a GlcNAc residue. Our data indicated the 
presence of al-3 and a l-4  branches of Fuc in fucoidan (Patankar, et al., 1993). The 
concentration dependence of fucoidan’s inhibition of selectin mediated processes and of 
sperm-ZP binding in the HZA was very similar (Foxall, et al., 1992). We therefore 
hypothesized that fucoidan may be inhibiting both these processes by similar molecular 
mechanisms (Patankar, et al., 1993). The natural extension of this hypothesis was that 
human sperm-ZP binding could also involve a selectin-like binding process. This 
observation indicated that a considerable overlap probably existed between the 
carbohydrate ligands responsible for mediating human sperm-ZP binding and the 
recruitment of leukocytes to the inflamed endothelium. We therefore proposed that initial 
human sperm-ZP binding could be a selectin-like event (Patankar, et al., 1993). However 
more proof was needed to support this hypothesis. In the first portion of this study we 
provide more evidence supporting an overlap of the carbohydrate ligands in the gamete 
binding and the immune system. Our analysis suggests that the known selectin ligands 
inhibit human sperm-ZP binding in the HZA.
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Direct Evidence Demonstrating the Role o f Carbohydrates in Human Sperm-ZP Binding 
Saling and co-workers recently suggested that a 95 kDa tyrosine kinase activity, 
ZRK, expressed on human sperm was the primary receptor responsible for mediating 
gamete binding (Burks, et al., 1995; McLeskey, et al., 1998). Two peptide sequences 
derived from the extracellular domain of ZRK were shown to inhibit human sperm-ZP 
binding. An analysis of the primary protein sequence of ZRK did not indicate the presence 
of a carbohydrate binding domain. Therefore the results obtained with ZRK did not support 
earlier evidence suggesting a role for carbohydrates in mediating initial human gamete 
binding. A review of the literature did not reveal any conclusive studies that could counter 
the suggestions made by Saling and co-workers (Burks, et al., 1995; McLeskey, et al., 
1998). We therefore focused our attention on obtaining direct evidence for the involvement 
of carbohydrates in initial human sperm-ZP binding. Specific chemical and enzymatic 
manipulations of the ZP oligosaccharide chains conducted in this study clearly indicate the 
importance of the glycan chains in mediating human gamete binding.
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MATERIALS AND METHODS
All of the chemicals utilized in this study were analytical grade and were obtained 
from Sigma Chemical Company, U.S.A unless otherwise indicated. Plates used for tissue 
culture were obtained from Falcon, U.S.A Prior consent from the Internal Review Board 
was obtained for collection of the human gametes. Eggs were obtained from donors 
undergoing in vitro fertilization at the Jones Institute for Reproductive Medicine. Eggs 
were stored in high salt solutions prior to use (Franken et al., 1989). Sperm samples were 
obtained from healthy donors who had fathered a child in the past two years.
Isolation o f Hemizona
Flame drawn micropipets were utilized for micromanipulation of the eggs and the 
hemizonae. Salt stored eggs were rinsed in HAMS-F10 media containing 0.5% human 
serum albumin (HAMS-HSA). The eggs were then bisected by a microsurgical cutting 
blade which was manipulated using a Narishige micromanipulator on an inverted phase 
contrast microscope (Nikon, Japan). The bisected eggs were aspirated vigorously in 
HAMS-HSA to remove the ooplasmic contents. Both the hemizona were transferred to a 
50 p.1 droplet of salt storage solution and stored at 4°C until used. To prevent evaporation 
the droplets were stored under mineral oil.
Isolation o f Human Sperm
Human sperm were isolated from semen using the swim-up procedure. After 
liquefaction, semen was pipeted into a 15 ml conical centrifuge tube. To this was added 5 
ml of HAMS-HSA that had been aseptically prepared and stored overnight at 37°C in a 5%
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C02 incubator. The diluted semen sample was centrifuged in a table top centrifuge at 400 
X g for 7 min. The supemant was discarded and the precipitate was resuspended in 2 ml of 
HAMS-HSA. The sample was centrifuged again at 400 X g for 5 min as before. The 
supernatant was discarded. To the pellet, which was highly enriched in the sperm, was 
carefully added 1 ml of HAMS-HSA. The tube was capped loosely and kept at an angle of 
45° in the 5% C 02 incubator set at 37°C for 1 h. The swim-up sperm were then carefully 
pipeted and placed in a 5 ml round bottom capped plastic sample tube. The concentration 
and the motility parameters of the swim-up sperm were analyzed by using a Hamilton- 
Thome Motion Analyzer, specially programmed to analyze human sperm motion 
parameters according to the World Health Organization (WHO) guidelines. Only sperm 
samples that exhibited progressive motility above 70% were used.
Hemizona Assay
Hemizona assay (HZA) was performed as described previously (Burkman, et al., 
1988). Matched hemizona were always used in the assay. Salt stored hemizonae were 
washed thoroughly by aspiration in HAMS-HSA. The control hemizona was then 
transferred to 25-50 pi droplets of swim-up sperm (0.7 million sperm/ml media) and kept 
under mineral oil to prevent evaporation. The test hemizona were transferred into identical 
droplets containing sperm (0.7 million sperm/ml media) from the same donor premixed 
with the known amount of the test substance. The control and the test droplets were stored 
under mineral oil to prevent evaporation. The incubation o f sperm and hemizona was 
carried for 4 h in a 37°C 5% C02 incubator as previously described (Burkman, et al., 
1988). Prior to the assay the sperm were incubated for 4 h with the test substances to 
check for any toxic effects and were assayed for motility as mentioned before. None of the
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substances tested in the HZA in this study significantly affected the motion parameters of 
the sperm. When analyzed by the Hamilton-Thome sperm motion analyzer, the progressive 
motility of the sperm in the presence of the test substances was > 75%.
After incubation for 4 hr, the control and test hemizonae were individually pipeted 
out and placed in 100 pi HAMS-HSA droplets. Each hemizona was then washed 15 times 
in separate HAMS-HSA droplets. The washed control and test hemizonae were placed in a 
50 pi HAMS-HSA droplet and the sperm bound to each were visually counted. To control 
for the quality of the hemizona, only the points where at least 20 sperm bound to the 
control hemizona were considered. For statistical accuracy, each assay was performed at 
least nine times. The effect of the test substance on sperm-ZP binding in the HZA was 
measured by calculating the HZI.
Periodate Oxidation o f Hemizona
Oxidation of the oligosaccharides expressed on the ZP was performed by treating 
the hemizona with sodium /w-periodate (SMP). For selective oxidation of the terminal 
NeuAc, the test hemizona were placed in a 50 pi ice cold droplet of phosphate buffered 
saline (PBS; 20 mM sodium phosphate pH 7.4 containing 150 mM sodium chloride) 
containing 1 mM SMP. The control hemizona were placed in 50 pi droplets of PBS 
containing 1 mM SMP and 100 mM ethylene glycol. Ethylene glycol was added to stop the 
SMP reaction. The droplets were covered with mineral oil to prevent evaporation and were 
kept on ice for 10 min. After incubation, the test hemizonae were promptly drawn out of 
the droplets and rinsed thoroughly by aspiration in PBS. The control hemizonae were also 
similarly rinsed with PBS. The test and the control hemizona were then separately placed
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under mineral oil in 50 pi droplets of PBS containing 100 mM sodium borohydride. This 
step was performed to reduce any aldehydes that may have formed during the oxidation 
with SMP on the hemizona. The reduction with sodium borohydride was performed for 1 h 
at room temperature. Following reduction, the control and the test hemizonae were washed 
thoroughly by aspiration in PBS and stored in salt storage solution until used in the 
hemizona assay.
A similar procedure was used for the oxidation of the terminal sugars except that 10 
mM concentration of SMP was used. The test hemizona were placed in a 50 pi droplet of 
10 mM SMP in PBS. The oxidation was performed for I hr at room temperature. The 
control hemizona were treated under identical conditions except that the incubation was 
done in the presence of ethylene glycol (100 mM). After treatment with SMP, the test and 
the control hemizonae were subjected to sodium borohydride reduction as described 
previously. The test and control hemizonae were stored in salt storage solution until used in 
the HZA.
Chemical Desialylation o f Human ai-Acid Glycoprotein
The NeuAc residues present on oligosaccharides expressed on human oti-acid 
glycoportein (AGP) were removed by acid hydrolysis as described previously (Varki and 
Diaz, 1984). AGP (10 mg) was dissolved in 2 ml 2 M acetic acid and heated at 80°C for 2 
hr. The acid was neutralized with pyridine. The reaction mixture was then concentrated to 
250 pi in an Amicon 10 kDa cutoff Centricon™ cartridge. The concentrated protein was 
resuspended in 2 ml of PBS and was again concentrated to 100 pi. This step was repeated 
at least 5 times to completely exchange the pyridine acetate present in the reaction mixture.
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Total protein retained was determined by assaying for absorbance at 280 nm which 
indicated a 70% recovery. A stock solution of 7 mg protein in 140 pi PBS was prepared 
for use in the hemizona assay.
Neuraminidase and Endo-fi-Galactosidase EBGase Treatment ofZP
Hemizona were obtained by microbisection of human eggs as described before. The 
hemizonae were washed thoroughly with PBS. Test hemizonae were placed in a 50 pi 
droplet of PBS containing 1 unit/ml Clostridium perfringens type X neuraminidase 
(Sigma). The control hemizona were placed in a 50 pi PBS droplet containing heat 
inactivated Clostridium perfringens type X neuraminidase under otherwise identical 
conditions. The droplets were covered with mineral oil to avoid any evaporation of the 
buffer and were incubated overnight at 37°C in a 5% CO2 incubator. After incubation the 
control and test hemizona were individually washed in PBS and stored in salt storage 
solution until further use in the HZA.
The conditions employed for EBGase treatment of the hemizonae was identical to 
the one used for neuraminidase digestion, except that 4 unit/ml of EBGase enzyme (V 
Labs) was used.
Staining o f Hemizonae with FITC-MAA
FITC-MAA lectin was used to determine the effect of chemical and enzymatic 
treatments on the test and the control hemizonae. Test and the control hemizonae were 
separately incubated for 15 min at room temperature in the dark in a 25 pi droplet o f PBS 
containing either 5 or 10 pg/ml of FITC-MAA. The hemizonae were immediately removed 
and washed thoroughly in PBS. The washed hemizonae were placed on a slide under a
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drop of Antiquench solution. Lectin binding to the hemizona was detected under a 
fluorescent scope (Nikon Microphot FX equipped with a 627 nm bandpass filter). The 
stained hemizona were photographed using the on-stage camera (FX-35WA). To make a 
quantitative estimate of the amount of FITC-MAA bound to the hemizona, the fluorescent 
microscope was set on an auto exposure mode and the amount of time of exposure 
estimated by the camera in order to get a clear picture was noted. An arbitrary scale for the 
amount of fluorescent staining of the hemizona was set as follows- (+++-I-) 1-5 sec; (+++) 
6-10 sec; (++) 11-20 sec; (+) 21-30 sec; (+/-) 31-40 sec; and (-) >40 sec.
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RESULTS
Sialyl Lewis' Inhibits Human Sperm-ZP Binding in the HZA
The structure of fucoidan resembled that o f sialyl Lewisx, the known selectin ligand. 
We therefore decided that sialyl Lewisx was a good candidate to be tested in the HZA for 
its effect on sperm-ZP binding. Incubation of the test hemizona with 1 mg/ml (10 mM) of 
sialyl Lewisx resulted in approximately 60% inhibition (HZI = 36 ± 14 [standard error])of 
sperm binding as compared to the matched control (Figure 7) (Clark et al., 1995). Human 
ai-acid glycoprotein (AGP), an acute phase glycoprotein derived from plasma glycoprotein 
and known to express minor amounts of sialyl Lewisx on its W-linked oligosaccharides also 
inhibited sperm-ZP binding in the HZA. Approximately 50% inhibition (HZI = 46 + 22) of 
sperm binding was observed when the test hemizona was incubated with 1 mg/ml of AGP 
whereas 5 mg/ml of this glycoprotein resulted in 99.3% inhibition ( HZI = 1) in the HZA 
(Clark, et al., 1995). Desialylated AGP obtained by chemical hydrolysis of the terminal 
NeuAc did not exhibit significant inhibition of sperm-ZP binding when assayed at a 
concentration of 1 mg/ml (HZI = 102 + 24) as shown in Figure 7. Desialylated AGP when 
tested at 5 mg/ml resulted in about 80% inhibition (HZI = 22 ±  10) (Clark, et al., 1995). 
However, at 5 mg/ml concentration of both the sialylated or desialylated AGP it is very 
likely that non-specific effects may ensue resulting in strong inhibition of sperm binding in 
the HZA.
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Figure 7: Inhibition o f human sperm-ZP binding in the HZA by sialyl Lewis* and AGP.
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Glycodelin-A
Dr. Oehninger in collaboration with Dr. Markku Seppala of the University of 
Helsinki, Finland, observed that placental protein 14 (PPM, previously also known as 
progesterone associated endometrial protein, PAEP) was the most potent inhibitor of 
human sperm-ZP binding in the HZA compared to other substances tested thus far 
(Oehninger et al., 1995). PPM is a glycoprotein that is temporally expressed in the uterus 
during pregnancy (Julkunen et al., 1985; Wahlstrom et al., 1985; Julkunen et al., 1986). 
This glycoprotein is abundantly found in the amniotic fluid from where it is isolated by 
using immunoaffinity chromatography (Julkunen, et al., 1985).
Contrary to previous reports, PPM is synthesized by the secretory and decidualized 
endometrium and not by the placenta (Julkunen et al., 1986; Julkunen et al., 1988). 
Expression o f this glycoprotein is also not regulated by progesterone. Therefore, the names 
PPM and PAEP given to this glycoprotein were misnomers. In addition, PPM was also 
found to be expressed in the seminal plasma and by the hematopoietic cells of the bone 
marrow (Julkunen et al., 1984; Kamarainen et al., 1994). The results that will be discussed 
below, clearly suggest a significant biological role for the glycans expressed on PPM 
obtained from the amniotic fluid. Therefore to avoid confusion about the nomenclature of 
the different forms of PPM we have renamed PPM or PAEP as Glycodelin (Gd) (Dell et 
al., 1995). PPM obtained from amniotic fluid is now referred to as glycodelin-A (Gd-A) 
whereas the seminal plasma isoform is now named as glycodelin-S (Gd-S). Similarly the 
new name given for the hematopoietic isoform of PPM is glycodelin-H (Gd-H) (Dell, et al., 
1995). This nomenclature will be followed throughout the remaining portions of this thesis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
48
Structural Characterization o f Gd-A Oligosaccharides
In addition to its ability to block sperm-ZP binding in the HZA, Gd-A was also 
shown to be an extremely potent suppressor of specific immune responses (Bolton et al., 
1987; Pockley et al., 1988; Pockley et al., 1989; Pockley and Bolton, 1989; Pockley and 
Bolton, 1990; Okamoto et al., 1991). Our studies with fucoidan, sialyl Lewisx and AAG 
strongly suggested that the oligosaccharide ligands involved in mediating human sperm-ZP 
binding closely mimicked the sugars recognized during specific immune responses. 
Therefore, we thought it likely that the contraceptive and immunosuppressive properties of 
Gd-A could be manifested by the glycans expressed on this glycoprotein. We undertook a 
study to characterize the structure of the Gd-A oligosaccharides.
The characterization of the Gd-A oligosaccharides was performed in collaboration 
with Drs. Anne Dell and Howard Morris from Imperial College, (London) and Dr. Markku 
Seppala. Fast atom bombardment-mass spectroscopy (FAB-MS) and electron spray-mass 
spectroscopy (ES-MS), two extremely sensitive tools for carbohydrate and peptide analysis 
were used for this analysis. The structural characterization studies were mainly done by the 
group at Imperial College and therefore only the main results of this collaborative study are 
discussed here as they provide valuable information absolutely essential for the conclusions 
of this present study. Therefore, the exact methodologies used for the structural 
characterization of the glycosylation sites and the oligosaccharides of Gd-A are also not 
described in detail here. A succinct flow chart of the various methodologies used is 
however included (Figure 8). For more information the reader is directed to the original 
manuscript (Dell, et al., 1995).
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Figure 8 : Schematic diagram of the strategies utilized for the structural characterization of 
the glycodelin glycans and for mapping of their glycosylation sites. For mapping of the 
glycosylation sites, the glycodelins were either treated with trypsin and analyzed by FAB- 
MS or treated with cyanogen bromide. Cyanogen bromide results in cleaving the peptide 
sequence at the methionine residues. The cleaved peptides obtained were analyzed by LC- 
ES-MS. For structural characterization o f the glycans, the proteins were treated with 
trypsin and the glycopeptides were isolated. FAB-MS profiles of the total glycan mixture 
were determined. In other experiments, the glycodelin glycans were released from the 
glycopeptides by the enzyme PNGase F. The free oligosaccharides were further analyzed 
using three different strategies. (1) The free glycans were subjected to sequential 
exoglycosidase digestions and the FAB-MS profiles recorded after each round of enzyme 
treatment. (2) For linkage analysis, the glycans were methylated and then hydrolyzed. The 
free hydroxyl groups of the released methylated monosaccharides were acetylated and 
analyzed by GC-MS. (3) To determine the fiicosyl linkages, the free glycans were 
permethylated and then subjected to mild methanolysis to remove the Fuc residues. The 
free hydroxyl groups were remethylated and the glycans analyzed by FAB-MS. The data 
obtained from all of these strategies was collectively used to determine the structures of 
the glycodelin glycans.
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The primary protein sequence of Gd-A carries three consensus sites for Ar-Iinked 
glycosylation. The glycosylation sites in Gd-A were determined by mapping the tryptic Gd- 
A glycopeptides by FAB-MS or by microbore liquid chromatography-electron spray-mass 
spectroscopy (LC-ES-MS) of the glycopeptides obtained after treatment with cyanogen 
bromide. FAB-MS and LC-ES-MS data indicated that only two of the sites, Asn 28 and 
Asn 63 were glycosylated. No 0-linked sugars were detected on this glycoprotein.
Analysis of the TV-linked oligosaccharides was performed using FAB-MS techniques 
coupled with specific glycosidase digestions as described previously by Dell and co- 
workers (Dell, 1987). The glycans expressed on Gd-A were either biantennary or 
triantennary. FAB-MS analysis of these glycans indicated the presence of highly unusual 
oligosaccharide chains on this glycoprotein (Figure 9). A vast majority of the TV-linked 
glycans found to be expressed on various mammalian glycoproteins carry the Gal01- 
4GlcNAc sequence on their non-reducing terminals (Figure 2 ). This sequence is referred to 
as the lacNAc sequence. However, approximately 50% of the Gd-A glycans expressed 
GaINAc0 l-4GlcNAc (lacdiNAc sequence) at their terminal ends in addition to the 
commonly observed lacNAc glycans (Figure 9). The expression of the lacdiNAc sequence 
in humans is highly restricted. It has been shown to be expressed on various pituitary 
glycohormones and also on recombinant human protein C expressed in the human kidney 
293 cell line (Grinnell et al., 1991; Grinnell et al., 1994). The terminal lacdiNAc glycans 
present in Gd-A were further modified by NeuAc and Fuc. Approximately 60% o f the 
glycans were sialylated and 20% were fucosylated (Dell, et al., 1995). All of the NeuAc 
was attached to the terminal Gal or GalNAc via a a2-6 linkage. The Fuc was attached to
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Figure 9: Structures of the oligosaccharides present in Gd-A_ The panel on the left shows 
the different glycans present on Asn 28 whereas the panel on right shows all of the glycans 
present on Asn 63. Open circles-Man, closed circles-Gal, open ellipse-NeuAc, open 
inverted triangle-Fuc, open squares-GIcNAc, and closed squares-GalNAc.
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the penultimate GlcNAc in a al-3 linkage. The al-3  fucosylation and sialylation of the 
same antenna were found to be mutually exclusive events. A significant number (30%) of 
the binantennary glycans carried both the lacNAc and lacdiNAc antennae within a single 
structure.
Structural Characterization o f Gd-S Oligosaccharides
As mentioned above, a seminal plasma isoform of Gd-A is also present. Since Gd-A 
exhibited potent contraceptive activities, it was initially puzzling why a potentially 
contraceptive glycoprotein could also be expressed in the seminal plasma as it could 
severely affect the sperm-ZP binding. It was considered very likely that Gd-S may not be 
expressing the unusual glycans expressed on Gd-A and could therefore not be 
contraceptive. Initial studies conducted in Dr. Seppala’s laboratory indicated major 
differences in the lectin binding profiles of both Gd-A and Gd-S. Wisteria floribunda 
agglutinin (WFA) is a lectin that selectively binds the GalNAc (Koistinen et al., 1996). In 
an ELISA-type assay, WFA was found to bind strongly to Gd-A. However, Gd-S did not 
bind WFA (Koistinen, et al., 1996). Similarly, Gd-S did not bind Sambucus nigra 
agglutinin (SNA) a lectin that binds to ot2-6 linked sialic acids (Koistinen, et al., 1996). 
These two observations indicated the absence of lacdiNAc and the a.2-6 linked sialic acid 
sequences in Gd-S. Gd-S was however found to avidly bind to Lotus tetragonolobus lectin, 
a lectin that binds to a l-3  and al-2  linked Fuc (Koistinen, et al., 1996). The lectin binding 
studies therefore indicated major differences in the structures of Gd-A and Gd-S glycans.
To conclusively determine the differences in the glycan structures o f Gd-A and Gd- 
S, the oligosaccharides attached to Gd-S were characterized by using ES-MS and FAB-MS
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(Morris et al., 1996). The strategies adopted for the characterization were similar to the 
methodologies utilized for the characterization of Gd-A glycans (Morris, et al., 1996) 
(Figure 8 ).
FAB-MS and LC-ES-MS analysis confirmed the differences in the Gd-S and Gd-A 
glycans observed by the lectin binding studies. As in the case of Gd-A, Gd-S also carried 
two TV-linked glycosylation sites but no O-linked oligosaccharides. Asparagine (Asn) 28 
and asparagine (Asn) 63 were both glycosylated as in the case of Gd-A. The first 
glycosylation site (Asn 28) carried only high mannose type glycans (Figure 10). All of the 
glycans present on Asn 63 were biantennary complex type oligosaccharides (Figure 10). 
However, none o f these biantennary glycans were of the unusual lacdiNAc type but were 
instead composed of the commonly occurring lacNAc sequences. Contrary to the Gd-A 
glycans which were highly sialylated, the Gd-S oligosaccharides were not sialylated. More 
than 80% of the glycans on asparagine 63 carried between 3 and 5 fucose residues per 
glycan. A substantial percentage of the glycans were terminated with the Lewis* (Gaipi- 
4[Fucal-3]GlcNAc-) and the Lewisy ([Fucal-2]Galpl-4[Fucod-3]GlcNAc-) sequence. 
The Lewisy sequence was totally absent in Gd-A.
Gd-S Does Not Inhibit in the HZA
FAB-MS analysis clearly indicated major differences in the structures of the Gd-S 
and Gd-A glycans. It was therefore reasoned that if the contraceptive activities exhibited by 
Gd-A in the HZA were mediated by its glycans, then Gd-S may exhibit differential activities 
in this gamete binding assay. To test this hypothesis, a comparative study of the effect of 
Gd-A and Gd-S in the HZA was performed at 1, 10 and 25 fig/ml concentration of the two















Figure 10: Glycans expressed on Gd-S. The structures shown in the left panel are the 
glycans found on Asn-28 and the ones on the right are the glycans expressed on Asn-63. 
Open circles-Man, closed circles-GaL, open ellipse-NeuAc, open inverted triangle-Fuc, and 
open squares-GlcNAc.
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glycodelins (Morris, et al., 1996) (Figure 11). Gd-A at 25 ng/ml inhibited sperm-ZP 
binding in the HZA by 90% (HZI = 6.6). At the same concentration Gd-S did not produce 
any effect on the number of sperm binding to the ZP (HZI = 93.3 ± 20). Similarly at 1 and 
10 pg/ml concentration of Gd-A approximately 30% (HZI = 70 + 33) and 70% inhibition 
(HZI = 33.3 ±  10) of sperm-ZP binding was observed respectively. At these 
concentrations, Gd-S did not inhibit but instead was found to slightly increase the number 
of sperm binding to the ZP (Figure 11).
Oxidation o f Terminal Sugars with SklP
SMP selectively oxidizes molecules carrying vicinal (adjacent) hydroxyl groups. 
Sugars carry hydroxyl groups on vicinal carbon atoms which can be oxidized by SMP 
(Figure 12). Under mild conditions (10 mM SMP at room temperature for 1 h) selective 
oxidation of cell surface associated oligosaccharides can be achieved (Van Lenten and 
Ashwell, 1971; Kalyan et al., 1982;Vacquier and Moy, 1977). Oxidation o f these vicinal 
hydroxyl groups results in the cleavage of the furanose or pyranose ring structure of the 
sugars and the formation of aldehydes on both sides of the oxidation site. The sites for 
SMP oxidation o f galactose and the products obtained in this reaction are shown in Figure 
13.
Many cell surface associated oligosaccharide chains are terminated with a NeuAc 
residue. NeuAc does not carry any vicinal hydroxyl groups within its ring structure. 
However, vicinal hydroxyl groups are present on the glycerol side chain attached to the C6 
carbon of NeuAc. Very mild oxidation conditions (1-2 mM SMP, at 0-5°C for 10 min) are 
sufficient to attack this glycerol chain of the NeuAc residues (Figure 14). Previous studies
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Figure 11: Effect o f Gd-S and Gd-A on human sperm-ZP binding in the HZA.












Figure 12: Fisher projection model of galactose is shown in panel A. Note the adjacent or 
vicinal hydroxyl groups present on the C2, C3 and C4 carbon atoms. Oxidation of vicinal 
hydroxyl groups by sodium m-periodate results in the formation of aldehydes as shown in 
panel B.
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Figure 13: Mild SMP oxidation of a Gal residue.
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Figure 14: Very mild SMP oxidation of the Terminal NeuAc. R= the rest of the glycan 
chain.
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indicate that under very mild conditions, the vicinal hydroxyl groups present on the C7-C8 
positions o f NeuAc are predominantly attacked resulting in the formation of a six carbon 
sugar referred to as heptulosonic acid (Figure 14). The internal sugars present in the 
oligosaccharide chain are not affected by this chemical treatment. Reactive aldehydes are 
generated after SMP oxidation reaction. Such reactive aldehydes can form imine linkages 
(>C=NH), also known as Schiffs base, with primary amine groups present in proteins. 
Such secondary reactions may pose problems when bioassays are being performed. The 
reactive aldehydes can however be converted to the less reactive alcohols by reduction with 
sodium boro hydride (100 mM at room temperature for 1 h) permitting the use of SMP 
oxidation to assess the role of the oligosaccharides in a bioassay. Therefore to assess the 
requirement for the human ZP oligosaccharide chains in mediating sperm-ZP binding, the 
hemizonae were treated with SMP, reduced with sodium borohydride and assessed for their 
ability to bind sperm using a standard HZA protocol.
Very M ild SMP Oxidation
Very mild SMP oxidation was performed to oxidize the terminal NeuAc residues. 
To control for any side effects that SMP or any possible impurities may have on the 
hemizonae, the control hemizonae were also treated under identical conditions with the 
same concentration of SMP. However, a 100-fold molar excess of ethylene glycol (100 
mM) was added to inactivate the periodate, thereby blocking oxidation of the ZP 
oligosaccharides. The test and the control hemizonae were then subjected to treatment with 
sodium borohydride.
The effect of very mild oxidation on hemizona was apparent when the test and the
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control hemizonae were assayed for their ability to bind to MAA, a lectin that specifically 
binds cx2-3 linked sialic acids (Figure 15). Lectin binding studies performed in our 
laboratory and those reported by others had indicated significant binding of FITC-MAA to 
the human ZP. The test hemizonae obtained after very mild SMP oxidation showed 
significantly less binding to FITC-MAA as compared to the controls (Figure 15). When 
tested for sperm-ZP binding in the HZA, approximately 30% inhibition was observed in the 
case of the test hemizona as compared to their matched controls (Table 4). This result 
clearly indicated that specific oxidation of the sialic acids expressed on the human ZP 
affected their ability to bind sperm.
Mild SMP Oxidation ofZP Oligosaccharides
Test hemizonae were treated under mild oxidation conditions with SMP (10 mM, 1 
hr at room temperature), to oxidize vicinal hydroxyl groups on both the ring and straight 
chains. The controls were treated under identical conditions except that 1 M ethylene 
glycol was added to inhibit the oxidation. Test and control hemizonae were subjected to 
sodium borohydride treatment. The HZA conducted with the test and the control under 
standard assay conditions indicated approximately 40% inhibition of sperm binding to the 
test hemizona (Table 4).
Enzymatic Treatment ofZP With Neuraminidase andEBGase Increases Sperm Binding
SMP oxidation of the ZP under mild and very mild conditions resulted in a 
significant decrease in sperm binding in the HZA indicating a role for the terminal sugar 
residues in mediating this interaction. We therefore decided to test the effect of enzymatic 
removal of some of terminal sugars of the ZP on sperm binding in the HZA Two enzymes
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Figure 15: Reduced binding of FITC-MAA to the SMP treated hemizona. Panel A is a 
control hemizona. Panel B is a matched test hemizona that was treated under mild SMP 
oxidation conditions. The control and the test zona were incubated with FITC-MAA, 
washed and visualized under a fluorescent microscope.
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Table 4: Effect of chemical and enzymatic treatments on human sperm-ZP binding in the 
HZA.
Treatment HZI
# of Sperm 
Bound to 
Control
# of Sperm 
Bound to 
Test




Mild SMP 61 ±10 73 ±23 26 ±4 22 <0.01
Oxidation
Very Mild SMP 70 ±11 42 ±16 36 ± 11 24 <0.05
Oxidation
Neuraminidase 297 ±45 60 ±10 150 ±22 22 <0.001
EBGase 710 ±232 28 ±10 104 ±25 14 <0.001
Neuraminidase
+ Mild SMP 20.7 ±4.4 76 ±10 12 ± 3 16 <0.001
Oxidation
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used in this study were neuraminidase and EBGase. Neuraminidase is a exoglycosidase that 
specifically cleaves NeuAc from the terminal ends of the oligosaccharides. In this study, 
neuraminidase (Type X, Sigma) obtained from Clostridium perfringens was used. This 
neuraminidase is known to be a highly purified preparation and is not found to contain any 
significant activities of other glycosidases or proteases. The Clostridium perfringens 
enzyme cleaves sialic acids in ot2-3 linkage with high affinity, although it also hydrolyses 
the a2-6 linked NeuAc at a slower rate.
We had previously observed that treatment of the ZP with this neuraminidase (1 
unit/ml) for 1 h did not significantly affect sperm-ZP binding in the HZA (Clark, et al., 
1995). However, NeuAc residues in mammals have been shown to carry glycolyl or acetyl 
groups. In some cases, a2-8 linked NeuAc has also been reported. It was therefore likely 
that if ct2-8 linked NeuAc or a chemically modified NeuAc residues were expressed on the 
human ZP, the Clostridium perfringens neuraminidase would either be unable to desialylate 
the oligosaccharides or could cleave the NeuAc at a very slow rate. Human ZP were 
therefore treated with the Clostridium perfringens neuraminidase for 8 h before analyzing 
the effects of desialylation in the HZA. The extent of desialylation was determined by the 
binding of FITC-MAA to the test hemizonae. Results similar to the one shown in Figure 15 
were obtained when the neuraminidase treated hemizona were labeled with FITC-MAA. 
Test hemizona were treated with the neuraminidase and the control hemizona were treated 
with heat inactivated neuraminidase.
Desialylated hemizona when assayed for sperm binding under standard HZA 
conditions gave an unexpected result (Table 4 ). Although oxidation of terminal NeuAc of
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the ZP oligosaccharides resulted in a decrease in sperm binding, enzymatic removal of this 
sugar caused a 2.5-fold increase in sperm binding to the test hemizona as compared to the 
matched controls which were treated with heat inactivated enzyme.
Previous studies have clearly indicated the presence of lactosaminoglycan sequences 
on murine and porcine ZP (Hokke, et al., 1994; Nagdas, et al., 1994). Therefore human 
hemizona were digested with a specific enzyme that degrades lactosaminoglycans 
(EBGase) by cleaving internal pi-4-linked Gal residues within these repeating co-polymers 
(Fukuda, et al., 1984). Digestion of the test hemizona with EBGase also resulted in 
approximately 4-7 fold increase in the number of sperm binding (Table 4).
SMP Oxidation o f Neuraminidase Treated ZP Inhibits Sperm Binding
The increase in sperm binding observed after treatment o f the ZP with 
neuraminidase and EBGase could be explained by the fact that the egg binding protein on 
the sperm recognize an internal oligosaccharide sequence. Therefore enzymatic removal of 
the outer NeuAc residues or polylactosamine type chains resulted in better binding of this 
egg binding protein to its ligands. In previous experiments with fucoidan it was observed 
that SMP was unable to oxidize the Fuc branches. It was thought that the high degree of 
sulfation present in fucoidan inhibited the chemical action of SMP, possibly due to the 
electrostatic effects (Clark and Patankar, unpublished results). A similar problem could 
possibly exist in the case of digestion of the ZP with SMP, where the high degree of 
sialylation of the ZP could result in inhibition of the SMP and so the internal sequences that 
were recognized by the egg binding receptor were not completely oxidized. In addition, 
SMP oxidation does not completely remove terminal sugar residues. For example, SMP 
oxidation results in the modification of the terminal NeuAc to heptulosonic acid, which
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remains attached to the oligosaccharide chain of the ZP (Figure 14 ). Such modified 
glycans could perturb the presentation of the ZP glycans and may therefore not be 
recognized by the egg binding protein of the sperm. Therefore incomplete oxidation or the 
presence of chemically modified terminal sugars could result in only a 40% inhibition of 
sperm binding to the mildly oxidized hemizona rather than a complete abrogation (Table 4).
To address this possibility, the test and the control hemizona were treated with 
neuraminidase as explained in the previous experiment. The neuraminidase treated 
hemizona were then subjected to mild SMP oxidation as mentioned before (10 mM SMP at 
room temperature for 1 h). These manipulations resulted in a 80% inhibition of sperm 
binding to the test hemizona as compared to the control (Table 4). Therefore removal of 
sialic acid followed by periodate oxidation resulted in substantial inhibition of binding.
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DISCUSSION
Specific Inhibition o f Sperm-ZP Binding by Sialyl Lewis*
Based on the structural and biological properties of the algal polysaccharide 
fucoidan, we had suggested that initial human sperm-ZP binding may involve a selelctin- 
like interaction (Patankar, et al., 1993). The results obtained in this study provide further 
evidence supporting this hypothesis. In previous studies it was observed that the Lewisx 
(Galpl-4[Fucal-3]GlcNAc), Lewisb or Lewis* (Gal pl-3[Fucal-4] GlcNAc) 
oligosaccharides were unable to block sperm binding in the HZA (Clark and Oehninger 
unpublished results). It was also observed that fetuin, a bovine glycoprotein expressing N- 
linked glycans similar to AGP but lacking the sialyl Lewisx epitope exhibited no inhibitory 
effect when assayed in the HZA (Clark and Oehninger unpublished observations). In this 
context the significant inhibition of sperm-ZP binding by sialyl Lewisx and AGP in the HZA 
is likely a specific effect (Figure 7). We have also demonstrated that desialylation of AGP 
renders it ineffective in inhibiting in the HZA (Figure 7). It is therefore very likely that the 
sialyl Lewisx oligosaccharide mimics the actual oligosaccharides expressed on the human 
ZP that are required to mediate the gamete interaction.
Relatively high concentration of sialyl Lewisx or AGP was required to obtain any 
significant inhibition of sperm binding in the HZA. However, it has been reported that sialyl 
Lewisx also inhibits selectin mediated adhesions in the same concentration range required in 
this study to inhibit human gamete binding (Varki, 1994). None of the carbohydrate ligands 
identified so far are capable of binding to the selectins with sufficient adhesive strength
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required to counter the extremely high shear forces that are experienced by the leukocytes 
(Varki, 1994). One possible reason that has been presented for this discrepancy is that the 
key to producing a very high affinity interaction lies in the manner in which the 
oligosaccharide ligands are being presented on the proteins or lipids. It has been suggested 
that these ligands when presented in patches or clusters serve as more effective ligands 
(Varki, 1994). Recognition of these clusters by the selectins results in a very high avidity 
interaction, leading to the binding of leukocytes to the endothelium even in the presence of 
high shear forces. Therefore, although sialyl Lewisx is the correct ligand for the selectins, its 
presentation in a monovalent fashion rather than a polyvalent manner results in low affinity 
interaction requiring considerably higher concentration of this oligosaccharide to block E- 
selectin mediated events in in vitro assays.
It is likely that a similar situation exists with the human sperm-ZP binding in the 
HZA. In the present study sialyl Lewisx was tested as a monovalent ligand. We have made 
several attempts to couple multiple molecules of different oligosaccharides to carrier 
proteins or to other polymeric supports. However, the presence of multiple hydroxyl 
groups on the sugar molecules poses a major problem in achieving specific labeling of the 
oligosaccharide chain. The reducing end (a hemiacetal) of the oligosaccharide is the only 
position that can possibly be used for tagging the molecule with chemical linkers, enabling 
polyvalent attachment of the sugars to carrier proteins or polymeric supports. The most 
convenient method of tagging the reducing end of the sugars is to react it with linker arms 
bearing primary or secondary amines leading to the formation of imines which could 
eventually be reduced to amines using sodium cyanoborohydride, a reaction sequence 
commonly known as reductive animation. We have synthesized various biotinylated
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reagents that carry 8-12 carbon atom linker arms with primary amine groups at their 
terminal ends. Our intention was to biotinylate the oligosaccharides of interest with these 
reagents which could allow us to present the sugars in a tetravalent manner when coupled 
with avidin, a protein known to bind up to four moles of biotin. A similar strategy was used 
by Rothenberg and co-workers (Rothenberg et al., 1993) for biotinylation of 
oligosaccharides. However, our studies indicate that although efficient coupling of mono- 
and disaccharides can be achieved, coupling o f higher oligosaccharides with these reagents 
results in extremely low yields (data not shown). We have therefore been unable to test 
sialyl Lewis’1 presented in a polyvalent fashion in the HZA.
In addition to polyvalent presentation, sialyl Lewis* may have to be presented in the 
context of an N-linked glycan on a protein platform. This possibility can be supported by 
the inhibition shown by AGP. Only 20-24% of the total glycans expressed on AGP carry 
the sialyl Lewis* epitope (Walz et al., 1990). As mentioned above, fetuin has no effect on 
sperm-ZP binding in the HZA. The only major difference in the glycans expressed on fetuin 
and AGP is the presence of sialyl Lewis* epitopes on the latter. Assuming that the protein 
structure of AGP does not play a role in the inhibition of sperm binding in the HZA (an 
assumption clearly supported by studies performed with desialylated AGP), it is clear that 
only 6% of the total glycoforms of AGP must be producing the inhibitory effect. Thus a 1 
mg/ml concentration of AGP which produces 50% inhibition in the HZA actually 
corresponds to only 200-240 jig/ml concentration of the AGP glycoform that bears the 
sialyl Lewis* epitope on its glycan chain. It is therefore possible that the sialyl Lewis* 
bearing AGP glycoform if isolated selectively could lead to a much more potent inhibition 
of sperm-ZP binding in the HZA In this context it can therefore be argued that precise
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
73
presentation of the appropriate oligosaccharide iigand(s) may be the key to obtaining very 
effective inhibition of the gamete binding process at low concentrations.
Specific inhibition of human sperm-ZP binding in the HZA by fucoidan, sialyl 
Lewisx oligosaccharide and AGP suggested that these glycoconjugates may be mimicking 
the structure of the actual ligand expressed on the ZP and thereby preventing its interaction 
with the egg binding protein expressed on the surface of the sperm. Our data indicate that 
sialyl Lewisx oligosaccharide inhibited both human sperm-ZP binding and E-selectin 
mediated adhesion over the same concentration range. These observations gave further 
support to our hypothesis that human sperm-ZP binding may involve a selectin-like event. 
More evidence in favor of this hypothesis was gained from the oligosaccharide structural 
analysis and the HZA inhibition profiles of the glycodelins.
Gd-A Glycans Inhibit Sperm-ZP Binding
Antibody binding studies performed by Seppala and co-workers indicated that all of 
the monoclonal antibodies produced against Gd-A also recognized Gd-S in Western blot 
analysis and also in dot blot assays (Seppala and Koistinen, personal communications). 
Sequencing data of 22 amino acids from the AT-terminal of Gd-A and Gd-S was exactly 
identical (Seppala and Koistinen, personal communications). LC-ES-MS analysis further 
indicated that fragmentation pattern of the peptides obtained from both the glycodelins was 
identical. All of this evidence therefore strongly indicates that the primary amino acid 
sequence of both Gd-A and Gd-S is identical. It is therefore very likely that the tertiary 
structure of both the glycodelins is also similar. Indeed both Gd-A and Gd-S exhibit similar 
electrophoretic mobilities when analyzed by non-denaturing or denaturing polyacrylamide 
gel electrophoresis (PAGE). Both the glycodelins have also been shown to form dimers in
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solution. Thus for all practical purposes it must be assumed that Gd-A and Gd-S are 
different glycoforms of the same protein synthesized by different tissues.
Inhibition studies performed in the HZA clearly indicate that while Gd-A is a potent 
inhibitor of sperm-ZP binding, Gd-S has no effect on this interaction (Figure 11). 
Therefore, considering the similarities between the protein structures of these two 
glycodelins it must be concluded that the differences in the biological properties exhibited 
by these glycoproteins are due to the expression of their significantly different W-linked 
glycans (Figure 9, 10). The glycodelins therefore provide additional proof that only specific 
glycoconjugates are capable of blocking initial attachment of the human gametes. The 
current goal in our laboratory is to synthesize the unusual glycans expressed on Gd-A to 
test their effect in the HZA. It is likely that these glycans could serve as efficient inhibitors 
of the gamete binding process and could therefore be used effectively for further research 
purposes (e.g. identification of the egg binding receptor present on human sperm) or could 
also be used to devise novel contraceptive agents. As will be discussed in Chapter IV of 
this thesis we have developed a new technique for the synthesis of glycopeptides. Using 
this method we have been able to efficiently synthesize the fucosylated lacdiNAc type 
biantennary glycopeptides and confirm their structures by FAB-MS analysis. We are 
currently collaborating with Dr. Thomas Plummer (Division of Molecular Medicine, New 
York State Department, NY) in order to synthesize all of the different Gd-A glycans and 
test their efficacy to block sperm-ZP binding in the HZA. It should however be noted that 
as in the case o f sialyl Lewis*, the proper presentation may be an absolute requirement for 
the Gd-A glycans to exhibit inhibitory activities in the HZA
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Human Sperm-ZP Binding as a Selectin-Like Event
Previous studies indicated that decidual extracts containing Gd-A were capable of 
suppressing thymidine uptake in both normal and mitogen-stimulated human mixed 
lymphocyte cultures (Bolton, et al., 1987). However selective removal of Gd-A from these 
extracts using anti-Gd-A antibodies resulted in a loss of these inhibitory responses. Gd-A 
was also shown to decrease the synthesis of interleukin-1 (IL-1) and interleukin-2 (IL-2), 
two cytokines that play a prominent role in initiation and maintenance of cytotoxic immune 
responses (Pockley, et al., 1989; Pockley and Bolton, 1989; Pockley and Bolton, 1990). 
Furthermore, this glycoprotein also inhibited the synthesis of IL-2 receptors by mitogen- 
stimulated cells (Pockley, et al., 1988). Additionally, Okamoto and co-workers had shown 
that Gd-A suppressed killing of the erythroleukemia cell line K562 by human natural killer 
(NK) cells in an in vitro assay (Okamoto, et al., 1991). The K562 cells have been 
conventionally known to be extremely good targets for the human NK cells. Based on the 
significant contraceptive and immunosuppressive effects exhibited by Gd-A coupled with 
our observations with fucoidan and sialyl Lewis', we hypothesized that the oligosaccharide 
chains expressed on Gd-A could also be responsible for mediating its potent 
immunosuppressive activities.
The highly unusual fiicosylated lacdiNAc type glycans have been previously shown 
to be expressed on human recombinant protein C by Yan and co-workers (Grinnell, et al.,
1994). This group of researchers have also shown that the fucosylated lacdiNAc sequence 
is a 15-20 fold more potent inhibitor of E-selectin binding to human umbilical vein 
endothelial cells (an experimental system used extensively to study the E-selectin) than 
sialyl Lewis' (Grinnell, et al., 1994). Our structural analysis of the Gd-A glycans therefore
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indicated that very potent selectin ligands are expressed on this glycoprotein (Figure 9). 
The presence of selectin ligands on Gd-A and its potent contraceptive and 
immunosuppressive activities therefore added support to our hypothesis that human sperm- 
ZP binding may involve a selectin-like interaction.
Initial Human Sperm-ZP Binding- A Carbohydrate Mediated Event
Extensive studies performed by many investigators have clearly indicated the 
involvement o f the ZP oligosaccharides in mediating gamete binding in the mouse 
(Wassarman, 1990). However, unambiguous evidence required for proving a similar role 
for the ZP glycans in human sperm-ZP binding had not been obtained. Studies performed 
by Saling and co-workers have suggested that a 95 kDa zona receptor kinase (ZRK) 
expressed on the human spermatozoa is the actual egg binding protein (Leyton and Saling, 
1989; Burks et al., 1995). Since all of the known protein tyrosine kinases can only bind to 
different peptides, the presence of ZRK has clearly instilled doubt about the role of the ZP 
oligosaccharides in mediating human gamete interaction (Aitken, 1995). Experiments 
performed with fucoidan have clearly indicated that specific glycoconjugates were capable 
of inhibiting sperm binding to the ZP (Mahony, et al., 1991). The present study was 
therefore undertaken to help resolve this controversy. The results obtained in our studies 
clearly indicate a role for the oligosaccharides in mediating human sperm-ZP binding.
The effect of chemical and enzymatic treatments on the ZP performed in this study 
provide strong evidence for the role o f carbohydrates in mediating human sperm-ZP 
binding. They also illuminate the molecular events that may be occurring during this initial 
gamete interaction. Desialylation or EBGase treatment of the ZP results in a 2.5-3 fold 
increase in the number of sperm being bound to the ZP (Table 4). At least two reasons
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were postulated to explain this substantial increase in sperm binding to the neuraminidase 
or EBGase treated ZP.
(1) It was theorized that the ligand for the egg binding protein present on the sperm is 
actually a peptide or protein epitope present on the ZP which is exposed due to the 
enzymatic removal of some of the terminal sugars;
(2) The egg binding protein of human sperm recognizes internal carbohydrate 
structures that are exposed due to the treatment of neuraminidase and EBGase.
Results obtained in this study, however, do not support the requirement of a 
protein-protein interaction for mediating initial human gamete binding. Studies with 
fucoidan, sialyl Lewis* AGP and the glycodelins clearly indicate that specific sugars can 
inhibit sperm-ZP binding. Furthermore, selective oxidation of the terminal sugars results in 
significant inhibition of sperm binding in the HZA. However, possibly the best data 
indicating the requirement of protein-carbohydrate interaction for mediating human sperm- 
ZP binding was obtained from the final experiment performed in this study. Mild oxidation 
of desialylated ZP inhibited sperm binding by 80% (Table 4). This result suggests that a 
majority (80%) of the sperm binding sites exposed after neuraminidase digestion are 
sensitive to mild periodate oxidation
The results of SMP treatment and neuraminidase digestion indicate that there may 
exist two modes for human sperm-ZP binding. The first mode depends in part upon the 
binding of terminal sialic acid. The second mode is independent of this terminal sugar. 
Binding in the presence of terminal sialic acid is weaker, either because of lower affinity or 
decreased numbers of binding sites of this type.
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In this context it is interesting to note that Testart and co-workers have reported 
that desialylation of human sperm by Arthrobacter ureafaciens neuraminidase also leads to 
3-fold increase in their ability to bind to the human ZP (Lassalle and Testart, 1994). Recent 
evidence indicates the presence of a 54 kDa sialic acid binding protein in the human uterine 
secretions (Baneijee and Chowdhury, 1997). This sialic acid binding protein has been 
shown to bind to a 23 kDa sperm plasma membrane protein (Baneijee and Chowdhury, 
1997). The interaction of these two proteins results in the desialylation of the human sperm, 
possibly by the activation of a sperm surface associated neuraminidase. Thus desialylation 
of either the spermatozoa or the ZP may lead to a substantial increase in sperm-ZP binding.
The results obtained in this study combined with those reported by other 
investigators suggest a new carbohydrate dependent model for initial human gamete 
interaction. When the gametes encounter each other, the sperm plasma membrane 
associated neuraminidase interacts first with the sialylated oligosaccharides of the ZP, 
providing sufficient affinity for initial weak attachment of the spermatozoa. The 
neuraminidase activity then cleaves the ZP associated sialic acid enabling access of the 
other lectin-like egg binding proteins of the sperm to bind strongly to the glycan sequences 
located beneath this terminal sugar. This process may be facilitated by oviductin, a 
glycoprotein that binds to the ZP in the oviduct and greatly enhances this interaction 
(O’Day-Bowman et al., 1996). Thus the transition between loose sperm attachment and 
subsequent tight primary binding of the human gametes could be explained by this ‘active 
digestion’ model combined with other glycoproteins that promote adhesion.
There is some indirect evidence that supports this model. Optimal sperm binding to 
the ZP requires an extended incubation of 4 h (Burkman et al., 1988). The HZA when
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applied as it is in our studies is considered to be a measure of tight binding (Burkman et al., 
1988) that leads to the induction of the acrosome reaction (Franken, et al., 1991). Such an 
extended period of incubation of the hemizona with the spermatozoa may be required to 
enable the desialylation of the ZP glycans by the sperm associated neuraminidase activity 
resulting in the exposure of the internal oligosaccharide chains. The tight binding of the 
sperm to the hemizona in the HZA may hampered due to the lack of the adhesion 
facilitating glycoproteins like oviductin that are present in vivo.
The results obtained with EBGase are also significant. Litscher and Wassarman 
(1996) isolated a restricted 55 kDa lactosaminoglycan-containing glycopeptide from mouse 
ZP3 glycoprotein that blocked murine sperm-ZP binding. Digestion of this glycopeptide 
with EBGase resulted in a substantial loss of glycan mass but did not affect its capacity to 
inhibit gamete interaction. By contrast, the results of our EBGase digestion studies indicate 
that lactosaminoglycan type chains block potential binding sites for human spermatozoa. 
These rather bulky extensions of glycans obscure the binding sites either directly by being 
attached to the potential binding glycans or indirectly by being in close proximity to them. 
Conclusion
The data obtained by studying the specific inhibition o f sperm-ZP binding by 
glycoconjugates and by specific chemical and enzymatic manipulation of the ZP clearly 
indicates that the oligosaccharides expressed on the ZP are absolutely responsible for 
mediating initial human gamete binding. Considerable work will be needed to determine 
exactly how human spermatozoa bind to the ZP. However, the evidence indicates that this 
interaction may be considerably more complex than previously thought. The involvement of 
sialic acid, the evidence for a sperm-associated neuraminidase, and other considerations
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discussed here support this conclusion.
Data obtained from experiments using sialyl Lewisx, AGP, and the glycodelins have 
provided further proof that this initial interaction between the gametes may involve a 
selectin-like interaction. On-going research initiatives undertaken in our laboratory will 
focus on the characterization of the exact molecular events taking place during the initial 
human gamete interaction. The current study has raised the possibility of the requirement of 
a sperm surface neuraminidase in mediating this process. Further proof will be needed to 
prove this requirement.
Utilizing the latest technological advances in oligosaccharide structural analysis 
coupled with the experiments performed in the HZA, it is very likely that substantial 
information can be obtained about the initial human gamete binding events. Our future 
goals will be oriented to reach this objective.




In our studies with the sperm-ZP binding system we observed that only those 
glycoconjugates that bear close resemblance to the selectin ligands are capable of inhibiting 
initial gamete interaction (Clark, et al., 1995). Fucoidan, sialyl Lewisx and the fucosylated 
lacdiNAc terminals present on some of the Gd-A glycans have all been shown to be potent 
ligands for the selectins (Foxall, et al., 1992; Grinnell, et al., 1994; Varki, 1994). These 
studies suggest that the carbohydrate binding specificities of receptors mediating gamete 
recognition and lymphocyte/leukocyte adhesion may overlap at least to a certain extent. 
However, monoclonal antibodies directed against selectins do not bind to human 
spermatozoa, suggesting the existence of distinct egg binding proteins on the human 
spermatozoa that can bind to the selectin ligands. Why would it be beneficial for 
carbohydrate-dependent recognition systems to overlap in the human? What type of 
selective advantage(s) would be gained under such circumstances? A review of the 
literature in human reproduction and glycobiology strongly suggests that such a 
convergence could facilitate the exchange of information necessary to protect the human 
embryo/fetus during its development. The studies that lead us to this conclusion are 
discussed below. However, some of the essential aspects of human reproductive 
immunobiology are reviewed first.
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The Ultimate Parasite
The human embryo formed after fertilization of the egg undergoes repeated cell 
divisions ultimately resulting in the formation of the blastocyst (Edwards, 1994). The 
blastocyst produces specialized cells known as the syncytiotrophoblasts. These cells invade 
and extravasate into the basement membrane of the uterine wall resulting in successful 
implantation of the embryo. Due to movement of the embryonic cells into the maternal 
endothelium the implantation is invasive resulting in close interactions between the 
embryonic cells like the trophoblasts and different components of the maternal immune 
system. Some of these embryonic cells express both the maternal and paternal antigens like 
the major histocompatibility complex (MHC) (Loke and King, 1991; Schmidt and Orr, 
1993). The paternal antigens are usually foreign to the mother’s immune system. The 
embryo is therefore usually referred to as a “semi-allograft”. In some cases of surrogate 
pregnancy, the embryo is a complete allograft. The expression of foreign antigens on the 
embryonic cells should therefore evoke a strong maternal immune response against the 
implanting embryo (Loke and King, 1991; Wegmann and Guilbert, 1992; Schmidt and Orr, 
1993). Evidence suggests that factors capable of producing a strong immune response are 
present throughout the period of pregnancy (Loke and King, 1991). The placenta expresses 
MHC class I antigens and some pregnant women also carry anti-HLA antibodies developed 
against the paternal antigens that theoretically should interfere with subsequent pregnancies 
with the same male (Regan et al., 1991). However, these women are usually capable of 
carrying the fetus to fiill term.
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Human decidua of early pregnancy contains considerable numbers o f natural killer 
(NK) cells (Loke and King, 1991). The NK cells are capable of killing cells that do not 
express the self MHC molecules. However, in most cases the presence of such factors that 
would normally launch allograft rejection of foreign tissues does not lead to fetal rejection. 
The fetus generally survives through the whole period of pregnancy. This situation is 
analogous to persistent infection with some parasites. Such parasites are capable of 
surviving immune challenge in the human hosts. These parasites are also adapted to obtain 
nutrients, and oxygen preferentially, characteristics shared by the fetus. It is for this reason 
that the embryo/fetus is sometimes referred to as the ultimate parasite.
It is generally accepted that specific suppressive factors are produced during the 
period of pregnancy inducing the immunotolerance that allows the fetal allograft to survive 
during its intrauterine development. Since pregnant women are not generally 
immunocompromised during or after pregnancy, it has been hypothesized that this 
immunosuppressive effect is highly localized to the uterus and expressed only during 
pregnancy (Hegde, 1991). Various factors like progesterone, a-fetoprotein, human 
chorionic gonadotrophin and the non-polymorphic MHC antigens such as HLA-G 
expressed on trophoblast at the fetomatemal interface have been implicated in maintaining 
this localized immunosuppressive effect (Hegde, 1991).
The Human Embryonic Defense System Hypothesis
Our recent findings and several other glycobiological observations suggest that 
specific glycoconjugates expressed by the endometrium in conjunction with those produced 
by the human embryo/fetus are responsible for manifesting significant contraceptive, anti­
inflammatory, and immunosuppressive effects. This system is based upon specific
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glycoconjugate interactions that abrogate initial sperm-egg binding, block selectin-mediated 
adhesions, and suppress lymphocyte-mediated responses. All of these activities expressed in 
a specific temporal fashion may serve to protect the developing embryo/fetus. We therefore 
refer to this model as the human feto-embryonic defense system hypothesis or the Hu- 
FEDS hypothesis (Clark, 1996). Known components of this system originate or are present 
in the glandular epithelium of the endometrium, the embryo/fetus, human amniotic fluid, 
and the human placenta.
The Different Components o f the Hu-FEDS
Human amniotic fluid contains mucins of fetal or endometrial origin that inhibit E- 
selectin mediated adhesions (Walz et al., 1990). The mucins probably mediate this effect via 
their covalently linked sialyl Lewisx terminated oligosaccharides. These mucins could 
therefore block acute inflammatory responses during pregnancy by inhibiting the primary 
adhesion of inflammatory cells. However, recruitment and activation of lymphocytes and 
other immune cells may require receptors other than the selectins. It is therefore likely that 
these mucins may not play a major role in potently inhibiting the lymphocyte-mediated 
responses.
Furthermore, the immune cell type that is found in the uterus during pregnancy is 
the CD3‘CD56+ natural killer (NK) cells (Sato et al., 1990). However, these decidual cells 
do not attack the fetus under normal circumstances and have greatly reduced cytotoxicity. 
It is therefore likely that other components are expressed in the uterus during pregnancy 
that are specifically responsible for abrogating such lymphocyte responses.
We believe that Gd-A is one of the major component of this glycoconjugate based
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immunosuppressive system. The expression of Gd-A is temporally and spatially regulated. 
During the menstrual cycle, Gd-A is not expressed in the proliferative endometrium but 
increases significantly from the fourth postovulatory day, peaking around day 12 (Julkunen, 
et al., 1986). Thus Gd-A expression is at a minimum during the peri-ovulatory period of the 
cycle. However, at the time of implantation of the embryo, Gd-A synthesis in the decidua is 
induced to very high levels (4-10% of total protein). This glycoprotein is also found in 
significant concentrations in the amniotic fluid, reaching a final concentration above 40 
pg/ml by mid-trimester.
As mentioned in the discussion section of Chapter n, Gd-A manifests several 
suppressive activities when tested in the immunological assay systems. Gd-A has been 
shown to be involved in inhibiting the thymidine uptake in stimulated lymphocytes, 
suppression of the cytokines IL-1, IL-2 and IL-2 receptor synthesis, and to block the lysis 
of K562 cells by the NK cells at low concentrations (Bolton, et al., 1987; Pockley, et al., 
1988; Pockley, et al., 1989; Pockley and Bolton, 1989; Pockley and Bolton, 1990; 
Okamoto, et al., 1991). Thus previous reports clearly suggest that Gd-A manifests potent 
immunosuppressive effects. Gd-A synthesis is highly localized. Although it is found in the 
blood of pregnant women, its maximal systemic concentration (2 (ig/ml) is well below that 
required for the suppression of the T- and NK cell responses (Julkunen, et al., 1985). The 
highly regulated temporal and spatial expression and the potent immunosuppressive effects 
manifested by Gd-A clearly meet all of the necessary criteria that would be necessary for an 
agent responsible for mediating immunotolerance of the embryo/fetus during pregnancy.
a-Fetoprotein (AFP) a glycoprotein that is synthesized by the fetal liver and the 
yolk sac has been associated with mediating immunosuppression of the fetal and the
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maternal immune responses (Deutsch, 1991). Suppression o f the fetal immune response 
during pregnancy is also likely to be crucial for maintaining tolerance of the developing 
human. AFP is also synthesized by hepatomas and other ovarian cancer cells and is 
therefore referred to as an oncofetal antigen (Ruoslahti, 1979). Previous studies indicate 
that AFP expressed during early pregnancy carries bisecting type TV-linked glycans (Figure 
16). The expression of the bisecting type glycans on AFP peaks around week 16 of 
pregnancy and then slowly declines so that at the time of birth no bisecting GlcNAc 
sequence is present on this glycoprotein (Deutsch, 1991).
Recent studies indicate that glycans bearing the bisecting GlcNAc sequences 
(Figure 16) suppress NK cell response when expressed on the cell surface. Electroinsertion 
of glycophorin, a major erythrocyte glycoprotein, into membranes of K562 cells makes 
them resistant to NK cell attack (el Ouagari et al., 1995). K562 are human erythroleukemic 
cells which do not express any MHC Class I molecules and are therefore efficiently killed 
by human NK cells. Glycophorin expresses one //-linked glycan in addition to many other 
CMinked chains (el Ouagari et al., 1995). A substantial number of the TV-linked glycans of 
glycophorin are of the bisecting type. Selective removal of these TV-linked glycans 
associated with glycophorin by the enzyme PNGase F completely eliminates its ability to 
suppress NK cell mediated responses. In addition stable transfection of K562 cells with the 
enzyme that catalyzes the synthesis of the bisecting GlcNAc sequence (GlcNAc transferase 
HI; Table 2) yields NK cell resistant transformants that show enhanced expression of this 
glycan on their cell surface (Yoshimura et al., 1996).
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Figure 16: Structure of the bisecting type biantennary glycan associated with the 
suppression of NK cell mediated cytotoxicity.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
88
The temporal expression of the bisecting type glycans on AFP during pregnancy 
points to an interesting feature. It is possible that expressing different type of glycans on the 
same carrier protein like AFP at different time points during pregnancy permits an 
additional control on the physiological events. Such dynamic changes in the glycosylation 
patterns of the same protein could possibly allow the same protein to perform different 
biological function(s). Thus such temporal variations in the glycosylation patterns probably 
makes the system extremely flexible to adapt to the ever changing physiological needs 
during pregnancy.
A Model For the Biological Actions o f Gd-A
As discussed in Chapter H, Gd-A is a potent inhibitor of human sperm-ZP binding 
in the HZA. To our knowledge, this finding is the first demonstration that a human 
glycoprotein can manifest both immunosuppressive and contraceptive effects. It is very 
likely that the temporal regulation of Gd-A synthesis prevents this contraceptive 
glycoprotein from interfering with the fertilization of the human eggs. As mentioned above, 
Gd-A is not synthesized during the peri-ovulatory cycle, the period when fertilization 
occurs. Subsequent induction of Gd-A synthesis 4-5 days after ovulation possibly creates a 
contraceptive microenvironment in the uterine cavity. Thus a ‘fertilization window’ may 
extend from the time of ovulation to the induction of endometrial Gd-A synthesis. Any 
spermatozoa that migrate through the uterine cavity after the synthesis of Gd-A has been 
initiated would encounter this contraceptive glycoprotein in the uterine fluid and thus 
would be unable to fertilize eggs released outside the appropriate temporal window.
A large number of NK cells are recruited to the uterus just after fertilization. Unlike
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the T- or B-cells, the NK cells do not require prior exposure to antigen to manifest 
cytolytic activity against their targets. The pre-embryo is therefore a potentially vulnerable 
target for the NK cell cytolytic responses. However, through these initial developmental 
stages the pre-embryo is still encapsulated in the ZP. It is probably at this time that the 
glycans expressed on the ZP provide a protective shield to successfully ward off any such 
immune responses. At about the same time, Gd-A is being increasingly synthesized by the 
decidual cells. Therefore, during the implantation process, when the embryo ‘hatches’ out 
of its protective ZP shield, Gd-A provides efficient protection against the NK cells. 
Implantation of the embryo therefore continues, unabated by the maternal immune system. 
It must be noted here that other glycoconjugates, as yet known or unknown, may also be 
produced during this process which also play a role in immunoprotection. However, it is 
true that Gd-A remains the best characterized immunosuppressive factor expressed during 
pregnancy.
The Gd-A Glyccms
As mentioned in the discussion section of Chapter II, Gd-A carries highly unusual 
fiicosyiated lacdiNAc type sequences. Such sequences have been previously shown to be 
potent selectin ligands. It is intriguing to note that mature schistosomes and filarial worms, 
two highly persistent parasites known to infect humans, also carry the fiicosyiated lacdiNAc 
sequence (Srivatsan et al., 1992; Kang et al., 1993). It will be interesting to investigate if 
these parasites utilize the same glycoconjugate based system of evading immune responses 
that are used to protect the human embryo/fetus from the maternal immune response. If 
these parasites do use a similar system for protecting themselves from the host’s immune 
response, the term parasite used for the human embryo/fetus could take on a new meaning.
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It should be noted that tumor cells that express selectin ligands exhibit enhanced 
tumorigenicity, suggesting that such glycans may also be protecting the cancer cells from 
cell-mediated immune responses.
All of the NeuAc expressed on Gd-A is linked in the a2-6 configuration to the 
terminal Gal or GalNAc. CD22, a B-cell maturation receptor has been shown to bind a2-6 
linked NeuAc. Although we have not been able to demonstrate binding of Gd-A to CD22 
by using affinity chromatography or Western blot analysis, it must be noted that a potential 
role for the cc2-6 linked NeuAc does exist. We are currently synthesizing the different 
glycans expressed on Gd-A to better characterize their roles in different immunological 
assay systems. Such studies would provide considerable information that would be vital to 
obtaining unambiguous evidence for the Hu-FEDS hypothesis.
Goals o f the Current Study
The specific expression of Gd-A during pregnancy, the occurrence of highly 
unusual but potent selectin ligands on this glycoprotein coupled with the expression of 
these glycans on parasites like schistosomes and filarial worms strongly suggests that a 
glycoconjugate based system protecting the developing human embryo/fetus exists. 
Considerable evidence will no doubt be needed to prove the Ku-FEDS hypothesis. It would 
also be extremely useful to determine if such a system of immunoprotection also exists in 
other placenta-bearing mammals. If so, it could be possible to utilize lower mammals or 
primates as models to study the existence of such a system. In the present study we have 
attempted to determine the expression of immunosuppressive carbohydrates on the surface 
of the human gametes. The rationale behind the current study is briefly summarized below.
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As mentioned previously, the glycans expressed on the ZP may also be playing a 
role in protecting the developing pre-embryo. A similar situation exists with the sperm. 
Insemination of the female results in recruitment of large number of neutrophils (Pandya 
and Cohen, 1985). Unless coated with anti-sperm antibodies, the neutrophils do not 
phagocytose the spermatozoa (D’Cruz et al., 1992). In most cases, the neutrophils kill the 
phagocytosed pathogens like bacterial and viruses by ingesting and then “bathing” them 
with reactive oxygen species like peroxides. Antibody coated sperm somehow manage to 
completely suppress the release of hydrogen peroxide and free radicals into the pahgosome 
of the neutrophils after phagocytosis (D’Cruz, et al., 1992). Furthermore, in most cases, 
the female immune system is recurrently exposed to the sperm antigens. However, usually 
no major immune response is produced against the sperm antigens. In those cases where 
anti-sperm antibodies are produced, the female usually experiences severe fertility 
problems.
Human gametes do not express any MHC class I molecules on their surface. The 
major immune cell type found in the uterus are the NK cells (70-80% of total immune and 
inflammatory cells). NK cells survey both immune and non-immune cells of the body for 
self Class I molecules and destroy those cells where such molecules are missing (Moretta et 
al., 1992). The NK cells are therefore continuously surveying for targets that lack the 
expression of MHC Class I molecules. The human gametes perfectly fit the profile for being 
good candidates for destruction by NK cells. In addition to the human gametes, the cells 
produced by the embryo, syncytiotrophoblasts, and the villous trophoblasts are all Class I 
negative (Vince and Johnson, 1995). The extravillous cytotrophoblasts express HLA-G, a 
restricted polymorphism MHC molecule known to suppress the NK-cell mediated
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cytotoxicity (Chumbley et al., 1994; Pazmany et ai., 1996). It is therefore very likely that 
these embryonic cells and the human gametes engage a system independent of MHC 
recognition to protect themselves against lysis by the NK cells.
Based on our previous studies with Gd-A, we hypothesized that the human gametes 
may also be evading immune recognition in the female reproductive tract by expressing 
specific glycoconjugates. Our goal for this study was therefore to determine if any 
immunosupressive glycans are expressed on the human ZP. The lack of sufficient numbers 
of human eggs precluded our ability to directly analyze the ZP glycans. Therefore in this 
study we attempt to probe the human ZP with specific lectins to determine if any o f the 
glycans previously implicated in mediating immunosuppression are expressed on their 
surfaces. In a previous study several lectins were tested for their ability to bind to human 
ZP (Shalgi et al., 1991; Maymon et al., 1994). Three lectins that were not tested in this 
previous study were analyzed in this study to determine if they could bind to human ZP. 
These lectins were selected because they bind to glycan sequences associated with 
glycoconjugates that suppress NK cell-mediated cytotoxicity. Sambuciis nigra agglutinin 
(SNA) was chosen because o f its specificity for terminal cc2-6 NeuAc linked to a 
lactosamine sequence (Gaipi-4GlcNAc) (Shibuya et al., 1987). As mentioned before, the 
a2-6 linked NeuAc is expressed on Gd-A. Wisteria floribunda agglutinin (WFA), a 
GalNAc binding lectin that is known to bind to the oligosaccharides carrying terminal 
fiicosyiated lacdiNAc type sequences (Nyame et al., 1989) that were also found on Gd-A. 
Both WFA and SNA have been shown to react with Gd-A in a carbohydrate dependent 
manner. Erythroagglutinating phytohemaglutinin (E-PHA) the third lectin used in this study 
has a very strict specificity for the biantennary and triantennary JV-linked glycans that bear a
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bisecting GlcNAc linked pi-4 to the P-linked mannose (Figure 17) (Cummings and 
Komfeld, 1982; Yamashita et al., 1983). This molecular probe was chosen because the 
bisecting type glycans recognized by this lectin have been shown to suppress NK cell 
activity when they are expressed on cell surfaces as discussed above.
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Figure 17: Oligosaccharide sequences recognized by E-PHA Ri and R2 are either a 
hydrogen or a carbohydrate group.
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MATERIAL AND METHODS
Materials and Human Samples
Fluorescein isothiocyanate (FITC)-labeled E-PHA, SNA and WFA were purchased 
from E-Y laboratories (San Mateo, CA, USA). Conalbumin, bovine milk 
galactosyltransferase, trypsin and uridine 5’-diphosphogalactose were purchased from 
Sigma (St. Louis, MO, USA). Human gametes were obtained and manipulated as explained 
in the materials and methods section of Chapter H.
Synthesis o f Inhibitors o f FITC-E-PHA Binding
Conalbumin was digested with trypsin after derivatization as previously described 
(Dell, et al., 1995) to yield glycopeptides (3 mg) that were enzymatically galactosylated by 
incubation with bovine milk P-galactosyltransferase (5 units) and uridine-5’- 
diphophogalactose (5 mg) for 24 h under optimal conditions (Barker, et al., 1972). A 
sample of the glycopeptides (100 mg) was digested with peptide N-glycosidase F to yield 
oligosaccharides that were analyzed by FAB-MS as previously described (Dell, et al.,
1995). This analysis confirmed complete galactosylation o f the conalbumin glycans to 
biantennary and triantennary bisecting type N-Iinked oligosaccharides that would react with 
E-PHA (Cummings and Komfeld, 1982; Yamashita, et al., 1983).
Lectin Binding Studies
The lectin binding to the human eggs and hemizona was performed as described in 
the materials and methods section of Chapter H. The swim-up sperm obtained as described 
in the methods and materials section of Chapter II were used for labeling with FITC-E-
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PHA. Non-acrosome reacted swim-up sperm were air dried overnight on a glass slide, 
methanol-fixed for 15 min and rehydrated in PBS as described previously (Cross and 
Overstreet, 1987). The slide was incubated in PBS containing FITC-E-PHA for 15 min, 
washed five times in PBS and inspected for fluorescence as described for the human egg 
and hemizona.
Labeling o f sperm with FITC-E-PHA in Solution
Swim up sperm at a final concentration of 0.5 million cells/ml in HAMS-HSA were 
incubated for 10 min at room temperature. The effect of the lectin on the sperm was 
visually observed under a phase contrast microscope.
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RESULTS
No detectable binding of FITC-SNA or FITC-WFA to whole human eggs was 
observed even when relatively high concentrations of the lectins (50 pg/ml) was used (data 
not shown). Extremely strong binding of FITC-E-PHA to the whole human egg was 
detected (Figure 18). This binding was detectable even at low lectin concentrations of 1 
(ig/ml. Optimal binding was seen at 10 (ig/ml concentration of FITC-E-PHA Hemizona 
obtained by microbisection of the eggs and removal of the cellular contents of the ooplasm 
were also found to bind strongly to FITC-E-PHA. For the hemizona the binding was 
observed even at 1 pg/ml concentration, however, optimal binding was observed at 5 pg/ml 
concentration of the lectin (Figure 18). There was a universal homogeneous binding of 
FITC-E-PHA to all eggs and hemizona tested. The binding of FITC-E-PHA was 
carbohydrate specific. A mixture of biantennary and triantennary bisecting type N-linked 
glycans obtained from conalbumin significantly reduced FITC-E-PHA binding to the 
hemizona (Figure 18).
In a previous study it was shown that immobilized human spermatozoa also bind E- 
PHA in a carbohydrate dependent manner (Cross and Overstreet, 1987). We were able to 
reproduce this result. Substantial labeling of immobilized spermatozoa was observed when 
incubated with 20 (ig/ml FITC-E-PHA (Figure 18). Labeling was found all over the 
surface of the sperm, although the acrosomal region was found to be more highly labeled. 
In other experiments we have also observed that live swim-up sperm bind to E-PHA in 
solution. In solution E-PHA has been shown to form tetramers. The lectin can therefore
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Figure 18: Binding of FITC-E-PHA to human gametes. FITC-E-PHA strongly binds to 
the whole human egg (Panel A). Panel B shows that the lectin binding to hemizona, 
indicating that the E-PHA binding sites exist on the ZP. The binding of this lectin can be 
considerable reduced by adding a bisecting type glycan bearing glycopeptides isolated and 
synthesized from conalbumin (Panel C). Panel D shows binding of the lectin to sperm.
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bind four moles of the bisecting type //-linked glycans. We have observed that incubation 
of the live sperm with low amounts of E-PHA results in rapid agglutination o f the sperm. 
When the sperm were incubated with 10 and 20 (ig/ml of the lectin at room temperature an 
almost instant aggregation of the sperm was observed (data not shown). Incubation with 1 
and 5 pg/ml required 5 min and 2 min respectively for the spermatozoa to aggregate (data 
not shown).
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DISCUSSION
In the present study we were unable to show binding of WFA and SNA to the 
human ZP. It is therefore unlikely that the fiicosyiated lacdiNAc or a2-6 linked NeuAc 
would be expressed on the human ZP. As mentioned earlier these sugars were found on the 
Gd-A glycans. We have however demonstrated that E-PHA binds strongly to the human 
ZP (Figure 18). E-PHA has been previously shown to be highly specific for bisecting type 
biantennary and triantennary iV-linked glycans.
As mentioned earlier, the human gametes do not express MHC class I antigens. The 
expression of bisecting type N-linked glycans may therefore be crucial for the suppression 
of NK cell-mediated responses especially after the egg is fertilized and the paternal 
contribution to the embryonic genome becomes detectable. Spermatozoa may also 
encounter NK cells during their movement through the uterus to reach and fertilize the egg. 
How spermatozoa are protected from maternal NK cells is currently unknown. It is 
however possible that the spermatozoa are also protected due to the presence of specific 
oligosaccharide sequences like the bisecting type AMinked glycans.
Conclusion
Using specific lectin probes we have clearly demonstrated the presence of glycans 
that may be involved in suppression of NK cell mediated responses. The results obtained in 
the next chapter clearly indicate that the bisecting type A-linked glycans can inhibit the NK 
cell function. These results therefore strongly suggest that glycoconjugate dependent
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suppressive system, as outlined in the Hu-FEDS hypothesis, plays a major role in 
protecting the human gametes and the developing embryo/fetus from the maternal immune 
responses.




Natural killer (NK) cells comprise approximately 5-10 % of the total lymphocyte 
population in the human body. The NK cells are known to provide immune surveillance by 
killing tumor and some virally infected cells that do not express self MHC molecules (See 
et al., 1997). Their physiological role therefore complements that played by the T- 
lymphocytes in mediating cellular immunity in mammals. The T-cells specifically recognize 
the foreign peptides presented on the self MHC molecules. Detection of such foreign 
peptides results in cytolysis of the target cells. However, in some virally infected or tumor 
cells the expression of MHC molecules on their surface is either lost or severely down 
regulated. The NK cells have the ability to recognize the absence of self MHC molecules 
and resulting in the killing of such targets. In essence, therefore the NK cells are involved in 
the recognition of “missing self’. This hypothesis was first put forward by Karre (1991).
The major phenotypic difference between the T- and the NK cells is the lack of the 
T-cell receptor (TCR) complex in the latter (Leiden et al., 1988). The T-cells are capable of 
identifying the various foreign peptides due to the presence of TCR. Similar to the gene 
recombination events that occur with the immunoglobulin molecules leading to the 
formation of antibodies with different antigen specificities, gene rearrangements lead to the 
various T-cell clones carrying TCR with different peptide specificities. A vast repertoire of 
T-cell clones is therefore generated with each clone capable of identifying a specific foreign 
peptide sequence when presented on the MHC molecules of the antigen presenting cells.
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The mechanism for target recognition utilized by the NK cells is however very 
different. Similar to the T-cells, different clones of the NK cells have been reported. Each 
o f these clones has a strict specificity to a particular MHC allele. For example based on 
their specificity for the HLA-C alleles, the human NK cells have been classified as Group 1 
and Group 2 clones (Moretta, et al., 1997). The group 1 clones recognize the Cw2, Cw4, 
Cw5, and Cw6 alleles whereas the group 2 clones recognize the Cwl, Cw3, Cw7, and Cw8 
alleles (Moretta, et al., 1997). Presence of these alleles on a normal cell inhibits their killing 
by the respective clones. Such alleles are therefore termed as “protective alleles”. NK cell 
clones specific for different alleles of the HLA-A and HLA-B molecules have also been 
reported (Moretta, et al., 1997). The allelic specificities of the different NK cell clones has 
been elucidated by transfecting HLA class I negative cells with the different HLA class I 
alleles and the ability of such cells to evade NK cell cytolysis. Experiments performed with 
HLA-C alleles have indicated the existence of a dimorphism in the amino acid residues at 
positions 77 and 80 in the a i domain of the HLA-C molecules. The protective alleles 
recognized by the Group 1 clones have a asparagine at position 77 and lysine at position 
80. Alleles that inhibit lysis mediated by the Group 2 NK cell clones have a serine at 
position 77 and asparagine at position 80 (Moretta, et al., 1997).
Recognition of the specific HLA class I alleles is mediated by different inhibitory 
receptors expressed on the surface of the NK cells. Such receptors are expressed clonally 
on the NK cells. One such inhibitory receptor is termed as p58, a 58 kDa protein (Moretta, 
et al., 1997). Two different molecular forms of p58 have been identified to be characterized 
on two different NK cell clones. The p58.1 inhibitory receptor has been found to recognize 
Cw4 as the protective HLA-C allele whereas NK cells expressing p58.2 require the Cw3
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allele to suppress their cytolytic responses (Moretta, et al., 1997).
Other known NK cell inhibitory receptors are Ly49 in the mouse, and p70, or pl40 
in the human. The intracytoplasmic tails o f all of these NK cell inhibitory receptors (also 
known as killer cell inhibitory receptors, KIR) carry the immunoreceptor tyrosine-based 
inhibitory motif (ITIM) which is used for cell signaling. Binding o f the receptor to its 
specific HLA allele results in the activation of intracellular phosphatases like the SHP-1 in 
the mouse resulting in a signaling cascade which leads to inhibition of the cytolytic 
response (Mason et al., 1997). It is significant that truncated forms o f all o f these inhibitory 
receptors lacking the ITIM motifs serve as activating receptors (also known as killer cell 
activating receptors, KAR) (Ciccone et al., 1996). There appears to be a delicate balance 
between the responses mediated by the activating and the inhibitory receptors that controls 
the cytolytic activity of the NK cell against a target cell.
Suppression o f NK cell Responses by Glycoconjugates
In addition to the mechanisms discussed above, the cytolytic responses mediated by 
NK cells have also been shown to be inhibited by various glycoconjugates. Gd-A potently 
inhibits lysis of K562 erythroleukemic cells by NK cells (Okamoto, et al., 1991). The 
bisecting type GlcNAc sequence (Figure 16) expressed on glycophorin has also been 
suggested to block NK cell responses (el Ouagari, et al., 1995; Yoshimura, et al., 1996). It 
is as yet very unclear how such glycoconjugates mediate their inhibitory effects. However, 
many KIR like CD94, NKG2, and NKR-P1A in the human and NKR-P1 in the rat have 
been shown to possess C-type lectin domains (Moretta, et al., 1997). Furthermore, 
truncated forms of all of these lectin receptors that do not carry the ITIM motifs have been 
shown to serve as KAR’s. The presence of the C-type lectin domains on these receptors
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strongly suggests a role for glycoconjugates in mediating NK cell recognition. The role of 
these lectin receptors is currently under intense scrutiny.
Focus o f the Current Study
In our previous study (Chapter IE) we have shown that the bisecting type //-linked 
glycan is expressed on the human gametes. It is therefore likely that expression of this type 
of glycan may be responsible for suppressing the anti-embryo/fetus responses that could be 
mediated by the maternal NK cells that are recruited in high numbers during the 
implantation process. However, concrete evidence for the involvement of the bisecting type 
//-linked glycan in suppressing the NK cell responses has not been clearly demonstrated. In 
this study we have therefore attempted to determine the effect of the bisecting type glycans 
on NK cell function. Inhibition of the NK cell cytolytic responses by such glycans could 
provide valuable evidence for the existence of a glycoconjugate based suppressive system 
responsible for protecting the human embryo/fetus from the maternal immune system as 
outlined in the Hu-FEDS hypothesis.
It must however be mentioned at the outset that all of the studies shown here 
should be considered with a restriction. Due to ethical considerations uterine NK cells 
could not be obtained from pregnant women. Therefore all of the experiments were 
conducted using peripheral blood NK cells. Uterine NK (CD2+, CD3', CD16+, CD56+, 
0094") cells are of a different phenotype than those found in the peripheral blood (CD2+, 
CD3', CD16+, CD56+/", CD94+/'). It is therefore possible that the effect of the glycans tested 
on the peripheral blood NK cells may not be similar to that on the uterine NK cells. 
Considering the constraint placed due to the unavailability of the correct biological 
materials, we believe that the peripheral blood NK cells can serve as an excellent model.
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Ovomucoid A Source fo r Bisecting Type Glycans
In Chapter III we utilized the glycopeptides enzymatically synthesized and isolated 
from conalbumin, a chicken egg albumin protein, as a source to obtain the bisecting type 
glycans used to block the binding of FITC-E-PHA to the hemizona. However, conalbumin 
was found to express very low level of the bisecting type biantennary glycan (5-10%) and 
high levels of the bisecting type triantennary glycan that also reacts with E-PHA (Corradi 
da Silva et al., 1994). As mentioned earlier, the bisecting type biantennary glycans 
expressed on glycophorin were found to be essential for inhibiting NK cell function. 
Conalbumin would therefore have yielded low amounts of the bisecting type biantennary 
glycans. Ovomucoid is a 23 kDa glycoprotein that is present in significant amounts in the 
chicken egg white. This glycoprotein has four major A-glycosylation sites (Asn-10, Asn-53, 
Asn-75 and Asn-69) with one partial glycosylation site (Asn-175) (Yet et al., 1988). A 
summary of the different carbohydrate chains expressed on the four major glycosylation 
sites is shown in Figure 19. Table 5 lists the amount of each glycan present on the four 
major glycosylation sites. A majority of the glycans expressed on ovomucoid are non 
galactosylated (Figure 19). However small amounts of these glycans bear 1-2 moles of 
galactose on each glycan chain (Table 5). The bisecting type biantennary glycan is present 
in either the non- or partially galactosylated form on 26, 33, 36 and 40% of the glycans at 
Asn-10, Asn-53, Asn-75 and Asn-69 respectively (Table 5) (Yet, et al., 1988). Overall, the 
non- or partially galactosylated forms of bisecting type biantennary glycan constitutes 
approximately 34% of the total glycans associated with ovomucoid. In addition, the 
bisecting type glycans with 3, 4, and 5 antennae (Figure 19) could be used as control 
glycans to test the specificity of the biantennary bisecting type glycans in affecting NK cell
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Figure 19: Major oligosaccharide sequences found in ovomucoid and their abbreviations 
which will be used in Table 5. The arrows indicate the preference shown by Gal-T for the 
Gal residues.
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Table 5: Percent distribution of the different ovomucoid glycans on its four major 
glycosylation sites
Structures % Glycan at Each Glycosylation Site
Asn-10 Asn-53 Asn-75 Asn-69
GlcNAC3Man3GlcNAC2 19 24 23 31
GalGlcNAc3Man3GlcNAC2 2 5 8 6
GaI2GlcNAc3Man3GlcNAC2 5 4 5 3
GlcNAc4Man3GlcNAc2 21 25 19 20
GalGlcNAc4Man3GlcNAc2 5 10 8 4
Gal2GlcNAc4Man3GlcNAC2 3 2 4 3
GlcNACgMariaGlcNAc^ 14 10 3 6
GalGlcNAC5Man3GlcNAc2 3 4 3 3
Gal2GlcNAc5Man3GIcNAC2 2 “ 1
GlcNAc6Man3GlcNAC2 11 8 4 2
GalGlcNACeManaGlcNACj 3 - 1 2
Ga^GlcNACeMariaGlcNAc^ - - - -
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function. We have therefore used ovomucoid to synthesize and isolate the different types of 
glycans required in this study.
Another point worth noting here is that we have used glycopeptides isolated by 
trypsin treatment of ovomucoid instead of free oligosaccharides. The glycopeptides were 
specifically used for the following reasons:
(1) As mentioned in the discussion section of Chapter II, only appropriately presented 
oligosaccharide chains seem to be active in biological assay systems. Extensive research 
performed with the selectins strongly supports this hypothesis. Therefore, it was very 
likely that the use of glycopeptides instead of the free oligosaccharides could help 
present these glycans in a more physiological configuration whereby they could better 
elicit their actual biological effects in the NK cell assays.
(2) Another advantage in using the glycopeptides was that the peptide sequence could 
be tagged with reagents like fluorescein to allow for sensitive detection during the 
enzymatic synthesis and isolation of the glycopeptides and possibly also during the NK 
cell assays if the need arises.
Trypsin has a fairly strict specificity for proteolytically clipping peptide sequences. 
This enzyme preferentially cleaves at the carboxyl terminal end of lysines or arginines 
present in the protein sequence. Analysis of the ovomucoid peptide sequence as listed in the 
Swiss-Prot database indicates that only four different glycopeptides could be obtained after 
trypsin treatment of ovomucoid (Figure 20). The smallest glycopeptide is GP-1 which 
carries the first glycosylation site (Asn-10) attached to a 7-mer. The glycosylation site at 
Asn-53 is attached to a 32-mer peptide. This glycopeptide is designated as GP-2. GP-3
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constitutes a 19-mer peptide which carries the glycosylation sites at Asn-69 and Asn-75. 
The partially glycosylated site at Asn-175 is present in GP-4 (minor glycopeptide) which is 
a 22-mer peptide. Since each glycosylation site carries glycan sequences as listed in Table 
5, different glycoforms of each of these glycopeptides exist. We have attempted to partially 
purify the bisecting type biantennary and triantennary glycans using E-PHA lectin affinity 
chromatography and analyzed them for their effect in the NK cell assays.




(GP-1 at Asn-10; mass range 2114 - 3047 Da)
DLRPICGTDGVTYTNDCLLCAYSIEFGTNISK 
(GP-2 at Asn-53; mass range 4950-5883)
ETVPMNCSSYANTTSEDGK 
(GP-3 at Asn-69 and Asn-75; mass range 4459-6361)
MINOR GLYCOPEPTIDE
CNFCNAWESNGTLTLSHFGKC
(GP-4 partially filled at Asn-175; precise mass range 
not yet determined)
Figure 20: The structures o f the peptide sequences attached to  the three major (GP-1, GP- 
2 and GP-3) and the minor (GP-4) glycopeptide.
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MATERIALS AND METHODS
Isolation o f Ovomucoid Glycopeptides
The general scheme used to isolate and enzymatically synthesize the galactosylated 
glycopeptides is given in Figure 21. Ovomucoid (2 gm) was dissolved in 20 mL of 8 M 
guanidine hydrochloride and reduced for 30 min at room temperature by adding 1.5 gm of 
dithiothrietol (Corradi da Silva, et al., 1994). The reduced protein was acetylated with 
iodoacetamide (3.5 gm) for 1 hr at room temperature. The reduced and acetylated protein 
was dialyzed for 24 hr using 1000 molecular weight cut-off dialysis membrane against 2 
mM tris-hydrochloride pH 8.0. The retained protein was lyophilized and resuspended in 2 
ml 8 M guanidine hydrochloride. This solution was diluted with 20 mM Tris-hydrochloride 
pH 8.0 to make the final concentration of guanidine hydrochloride 2 M. TPCK-treated 
trypsin (20 mg) was added to the solution that was subsequently incubated at 37°C for 12 
hr. The reaction was terminated after 4 hr by heating the solution on a boiling water bath 
for 3 min. The solution was dried on a SpeedVac apparatus (Savant) and resuspended in 2 
ml of 0.1 M pyridine acetate (pH 5.4) buffer. Insoluble precipitate was removed by 
centrifugation. The precipitate was primarily composed of insoluble peptides as indicated 
by the carbohydrate analysis using the phenol-sulfuric acid assay (Dubois et al., 1956). The 
supernatant was desalted on a BioGel 2 (2.5 cm X 60 cm) column. Elution of the 
glycopeptides was monitored by phenol-sulfuric acid assay and by absorbance at 280 nm. 
Approximately 93% of the glycopeptides eluted in the void volume of the column. 
Fractions containing the glycopeptides were pooled and dried completely at low pressure.
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Figure 21: Schematic diagram of the strategy utilized for isolation and synthesis of the 
different ovomucoid glycopeptides.
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The dried sample was separated on the basis of size on a BioGel P4 (2.5 cm X 60 
cm) column. The column was eluted with 0.1 M pyridine acetate (pH 5.4) and small 
aliquots (10 |il) were drawn for carbohydrate analysis using the phenol sulfuric acid assay. 
The high molecular weight (HMW) and low molecular weight (LMW) glycopeptides were 
pooled separately and dried completely. The amount of glycopeptide obtained was 
determined by phenol-sulfuric acid assay. 6 pinoles of HMW glycopeptides (assuming an 
average molecular weight of 3000 Da) and 8 pmoles of LMW glycopeptides (assuming an 
average molecular weight of 2500 Da) were obtained.
Galactosylation o f Ovomucoid Glycopeptides
The ovomucoid glycopeptides (5 pi) were dissolved in 600 pi of Gai-T buffer (20 
mM Na-cacodylate, pH 7.0, containing 1 mM magnesium chloride and 1 mM calcium 
chloride and 0.02% sodium azide). 300 pi of Gal-T buffer containing 30 pmoles of UDP- 
Gal and 1 X 107 cpm of UDP-[3H]Gal was added followed by 10 units of Gal-T (Sigma) in 
100 pi Gal-T buffer. The reaction mixture was incubated for 12 h at 37°C. Another aliquot 
of Gal-T (10 units) and 10 more pmoles of UDP-Gal in 100 pi Gal-T buffer were added to 
the reaction which was incubated for another 12 h at 37°C. The galactosylated 
glycopeptides were separated by desalting on a BioGel P2 column as before. The elution of 
the radiolabelled glycopeptides was followed by liquid scintillation. Fractions containing the 
glycopeptides were pooled and dried under low pressure. A 50 pg sample of the 
galactosylated glycopeptides was forwarded to Dr. Anne Dell for FAB-MS analysis. 
Separation o f Galactosylated Glycopeptides by E-PHA Chromatography
To avoid over loading, 30-45 nmol of the glycopeptides were separated on the E-
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PHA-Affigel 10 (5 ml column; 6 mg lectin/ ml of gel) per run. The lectin column was 
washed thoroughly with phosphate buffered saline (PBS; 20 mM sodium phosphate pH 7.4 
containing 150 mM sodium chloride and 0.02% sodium azide). The glycopeptides (200 pi) 
in PBS loaded on the column. The column was washed with 25 ml of PBS and fractions 
(2.5 ml) were collected. The bound glycopeptides were eluted with PBS containing 0.4 M 
GalNAc. The elution of the unbound and bound glycopeptides was determined by liquid 
scintillation counting of a small aliquot (20 pi) of the total fraction. After performing 
several runs on the column, 750 nmoles (1.5 mg) of the glycopeptides were isolated from 3 
pmoles of the galactosylated. Approximately 10-20 mg of the glycopeptides obtained after 
E-PHA chromatography were analyzed by FAB-MS.
Coupling of E-PHA to AffiGel-I0
AffiGel-10 (BioRad; 6 ml) was transferred to a 10 cm column and washed 
thoroughly to remove the isopropanol used to store the gel. The gel was then equilibrated 
with 0.1 M morpholinosulfonic acid buffer (MOPS), pH 5.0. 40 mg of E-PHA (EY 
Laboratories) was dissolved in MOPS (3 ml) and the protein solution was added to the gel 
slurry. The column was capped tightly and rotated end over end at 4°C overnight. To cap 
any unreacted reactive groups on the gel, 1 M ethanolamine was added to make the final of 
ethanolamine 100 mM. The column was again capped and rotated for 2 h at 4°C. The 
column was then washed extensively with PBS followed by 1 M sodium chloride to remove 
any non specifically bound protein. The washings were collected and analyzed for unbound 
protein by determining the absorbance at 280 nm. Protein analysis indicated that 30 mg of 
E-PHA (5 mg/ml of gel) was bound to the AffiGel-10. The column was reequilibrated in 
PBS.
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Isolation o f Peripheral Blood NK Cells
The peripheral blood NK cells were isolated as described earlier. Briefly, 60 ml of 
heparinized blood was obtained from a healthy male individual. The mononuclear cells were 
separated from the red blood cells by density gradient centrifugation using Histopaque 
1077 (Sigma). The mononuclear cells (10 ml) were diluted with an equal volume of RPMT- 
1640 media containing penicillin-streptomycin-amphotericin cocktail obtained from Gibco 
and 2% fetal calf serum (RPMI-2) and centrifuged for 10 min at 250 X g using a swinging 
bucket type rotor at room temperature. The pelleted cells were washed one more time with 
RPMI-1640 media containing penicillin-streptomycin-amphotericin cocktail obtained from 
Gibco and 10% fetal calf serum (RPMI-10) under the same conditions. The pelleted cells 
were resuspended in 5 ml of RPMI-10 and loaded on 20 ml nylon wool columns presoaked 
in RPMI-10 at 37°C. The nylon wool columns were prepared by taking 1.8 gm o f well 
combed nylon wool in a sterile 60 ml column. The nylon wool was washed with 40 ml of 
37°C RPMI-2 followed by 30 ml of 37°C RPMI-10. The column were capped and 
incubated at 37°C in a 5% CO2 incubator for at least 1 hr before loading the cells.
After loading the cells on the columns, some of the media was allowed to flow 
through the column to ensure that all of the cells were in contact with the nylon wool. After 
approximately 5 ml of RPMI-10 was slowly added on the column, the columns were 
capped and incubated at 37°C in the 5% CO2 incubator for 1 h. After incubation the non­
adherent cells highly enriched in NK and T-cells were obtained by washing the nylon wool 
column with 40 ml of 37°C RPMI-10. The eluted cells were collected in a 50 ml sterile 
centrifuge tube. The cells were pelleted by centrifugation at 250 X g for 10 min. Pelleted 
cells were washed with RPMI-2 as described before and were then resuspended in 2 ml of
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RPMI-2. Typically, approximately 80-90 million cells were obtained at this point. The cell 
counting was performed by using a hemacytometer. Viability o f cells was checked by the 
trypan blue dye exclusion assay. On an average more than 90% of the cells were found to 
be viable.
The cells were then subjected to negative antibody selection. A cocktail of mouse 
antibodies directed against the T-and B-cell epitopes was added to the cell suspension. The 
antibodies used were anti-CD3, anti-CD 14, and anti-CD 19. The cells were incubated with 
these antibodies on ice for 30 min. The cell suspension was gently shaken every 5 min to 
enable proper binding of the antibodies to the contaminating T- or B-cells. The antibody 
bound contaminating cells were separated from the NK cells by incubating the cell 
suspension with 1 ml of magnetic beads coated with goat anti-mouse IgG (BioDesign) on 
ice for 30 min. Prior to use the magnetic beads were thoroughly washed five times with 
RPMI-2 in a round bottom sterile plastic tube. After each wash, the beads were isolated by 
holding the tube against a strong magnet (BioDesign). The media was gently pipetted out 
and fresh RPMI-2 media was immediately added. The tube was taken apart from the 
magnet and the beads were gently resuspended in the media.
Beads attached to the contaminating cells were removed by placing the tube against 
a strong magnet as above. The media containing the NK cells was carefully pipetted out 
and a fresh 1 ml aliquot of the magnetic beads to the cell suspension. The separation was 
performed as described above. The cell suspension highly enriched in the NK cells was 
centrifuged at 250 X g to pellet the cells. The pelleted cells were washed with RPMI-1640 
media containing penicillin-streptomycin-amphotericin cocktail obtained from Gibco and 
10% human AB serum (RPMI-10-AB). The pelleted cells were finally suspended in 2-3 ml
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of RPMI-10 AB. Typically 15-18 million cells were obtained at this point in the isolation. 
The phenotype of the cells was checked by incubating approximately 100,000 cells in a 500 
pi microcentrifuge tube with a cocktail of mouse anti human CD 16 and mouse anti-human 
CD56 antibodies (5 pg/ml concentration of each antibody) on ice for 30 min. The cells 
were briefly pelleted and washed three times with 400 pi of RPMI-10. The cells were 
finally incubated with 5 pg/ml concentration o f FITC labeled goat anti-mouse IgG for 30 
min on ice. The FITC labeled antibody was washed off by centrifugation as above. The 
cells were then placed on a microscope slide and the number of FITC labeled cells in 
different fields of view were counted. On an average more that 85% of the total cells were 
fluorescent, indicating a high number of NK cells in the isolate.
Labeling o f K562 Cells with 51 Cr
The K562 target cells were obtained from American Type Tissue Culture (ATCC). 
The cells were cultured in RPMI-10 for 3 weeks before labeling. 2 million cells were used 
each time for labeling. The cell counts were performed using a hemacytometer. Viability of 
the cells was determined by the trypan blue dye exclusion assay. The cells used for labeling 
were resuspended in 2 ml of RPMI-10 and incubated at 37°C for I hr in the presence of 
100-200 mCi of Na2[51Cr]20?. After incubation the cells were washed 4 times with 10 ml of 
RPMI-2 and finally once with 10 ml of RPMI-10. The pelleted cells were finally 
resuspended in 4 ml of RPMI-10.
Cytolytic Assays
The NK or LAK cytolytic assays were performed as described in an established 
protocol. General paradigm used for performing these assays is shown in Figure 22.
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NK Cells Isolated From Healthy Donors
1 I
Cultured for 48 h with or 
without IL-2 
and Test Glycopeptide
Cultured for 48 h with IL-2
K562 Target Cells Labeled with 51Cr
NK and Labeled K562 Cells 
Cultured for 4 h
NK and Labeled K562 Cells 
and Test Glycopeptide 
Cultured for 4 h
Amount of 51Cr Released 
in the Medium Determined
Amount of 51Cr Released 
in the Medium Determined
Figure 22: Schematic representation of the general procedure for performing the NK cell 
assays in the presence of the test glycopeptides.
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The NK cells (approximately 2 million cells/ml media final concentration) were 
incubated in 12-well tissue culture plates (Falcon) in the presence or absence of appropriate 
amounts of the test glycopeptides for 48 h at 37°C in a 5% CO2 incubator. For the LAK 
assays, the NK cells (approximately 1 million cells/ ml media, final concentration) were 
cultured in 12-well tissue culture plates in the presence of 6000 IU of IL-2 (R&D Labs) in 
the presence or absence of the appropriate amounts of the test glycopeptides. Cells were 
cultured for 48 hr in a 5% CO2 incubator. Cytolytic assays were then performed using these 
cultured NK or LAK cells. In some cases, the treated LAK cells were transferred to a 15 
ml sterile centrifuge tube and washed three times with RPMI-10 to remove the 
glycopeptide.
Viability of these treated NK or LAK cells was checked by the trypan blue dye 
exclusion assay. The cytolytic assays were performed in 96-well round bottomed tissue 
culture plates (Falcon). The total volume of each assay was 200 pi. Appropriate numbers 
of the treated or untreated NK or LAK cells were added to the wells. The total volume in 
each well was made 195 pi by adding the necessary amount of RPMI-10 media. This step 
was followed by adding 5 ml of the 51Cr-labeled K562 (5000 cells total) targets. All of the 
assay were performed in triplicates. To determine the amount of spontaneous release of the 
5lCr activity from the targets, 5 pi of the labeled K562 cell suspension was added to 195 pi 
of media in six separate well. For calculating the maximal release, 5 pi of the 51Cr-labeled 
target cell suspension was added to six separate wells containing 195 pi of 5% Triton- 
X I00 in PBS. The plates were briefly centrifuged for 2 min at 1000 rpm and were 
incubated at 37°C in a 5% CO2 incubator for 4 hr.
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The plates were again centrifuged briefly as before. A 100 pi aliquot was carefully pipeted 
out from each of the wells and was assayed for the amount of slCr in a gamma counter 
(Beckmann). The amount of cytolysis was determined by the following calculation-
% Cytolysis= (Amount of slCr released in test) - (Amount of Spontaneous 5ICr 
release)/(Amount of maximum 5ICr release)-(Amount of Spontaneous 51Cr release) X 100.
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RESULTS
Isolation o f Ovomucoid Glycopeptides
The general scheme used to isolate and enzymatically synthesize the galactosylated 
glycopeptides is given in Figure 21. Size exclusion chromatography of the ovomucoid 
glycopeptides on a BioGel P4 column resulted in the isolation of HMW and LMW 
glycopeptide fractions (Figure 21). It was realized that these glycopeptide fractions were 
substantially contaminated with peptides. It has been previously reported that immobilized 
E-PHA could be used to purify biantennary and the triantennary bisecting type glycans that 
have Gaipi-4GlcNAc attached via a P1-2 linkage to the a  1-6 linked mannose of the core 
(Figure 17). Such a purification step could also lead to removal of the peptide sequences 
from the glycopeptides expressing these glycans. However, as mentioned before, a majority 
of the glycans expressed on ovomucoid are either non- or partially galactosylated. Both the 
HMW and LMW glycopeptides were therefore enzymatically galactosylated and their 
glycans were analyzed by FAB-MS.
The FAB-MS profiles of the oligosaccharides linked to HMW and LMW 
glycopeptides are shown in Figure 24. The structures of the glycans associated with these 
glycopeptides is shown in Figure 25. Both the HMW and LMW glycans showed similar 
major ions with only minor variations (Figure 24). Such minor variations are usually 
observed in FAB-MS spectra due to protonation or addition of a sodium ion. 
Fragmentation is also not perfectly reproducible by FAB-MS below 0.1 Da. The FAB-MS 
profiles indicated that substantial galactosylation of both the glycopeptide fractions had
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Figure 23: BioGel P4 elution profile of the trypsinized ovomucoid glycopeptides. 
Ovomucoid glycopeptides were applied to a column of BioGel P4 (60 X 2.5 cm) and 
eluted in 0.1 M pyridine acetate, pH 5.4. A 5 ml aliquot was obtained from each fraction 
(2.8 ml) and subjected to phenol-sulfiiric acid assay (Dubois et al., 1953). Fractions 24-27 
and fractions 28-37 were pooled separately and designated as HMW and LMW 
respectively.
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Figure 24: FAB-MS profile of oligosaccharides derived from glycopeptides in the LMW 
(Panel A) and HMW (Panel B) after reaction with Gal-T. The major peaks identified in the 
text have been labeled.
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Figure 25: Structures of glycans associated with the HMW and LMW glycopeptides
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been achieved. Comparison of the abundance of the molecular ion peaks for the different 
glycans indicated that approximately 60% of the HMW and 50% of the LMW 
glycopeptides had been galactosylated.
Separation o f the Glycopeptides by E-PHA Column Chromatography
The biantennary and triantennary bisecting type glycans present in the HMW and 
LMW fractions were isolated chromatography on a immobilized E-PHA column. On an 
average 20-25% of the total [3H]Gal labeled glycopeptides loaded were found to bind to 
the column (Figure 26). To obtain sufficient amounts of the material the E-PHA 
chromatography was performed several times. Each run was found to be highly 
reproducible. A representative profile of the separation is shown in Figure 26. The bound 
(E-PHA*) and the unbound (E-PHA’) HMW and LMW glycopeptide fractions from all of 
the runs were pooled and their glycans analyzed by FAB-MS. Analysis of the E-PHA* 
HMW and LMW glycopeptides indicated a significant enrichment of the biantennary 
bisgalactosylated (m/e -2316) and the triantennary tris-galactosylated (m/e -2765) 
bisecting type glycans (Figure 27). Other significant peaks at m/e -2560 and -2118 
represent the triantennary bisgalactosylated and the biantennary monogalactosylated 
bisecting type glycans respectively, obtained due to under galactosylation of the 
glycopeptides (Figure 27). FAB-MS spectra of the E-PHA'glycopeptides indicated the 
presence of the tetraantennary (m/e —3214) and pentaantennary (m/e —3460) bisecting type 
glycans in addition to the biantennary and triantennary bisecting type oligosaccharide 
sequences (Figure 28). Undergalactosylated forms of the tetra and pentaantennary 
oligosaccharides were also found to be present (m/e -3010 and 3255) (Figure 28). 
Presence of biantennary and triantennary bisecting type glycans in the E-PHA’ fractions
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Figure 26: Separation of HMW glycopeptides on a column of E-PHA-agarose (6.0 X 1.0 
cm; 5 mg E-PHA/ ml gel). The arrow indicates the point where elution with buffer 
containing 0.4 M  GalNAc was initiated to remove bound glycopeptides.
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Figure 27: FAB-MS analysis of oligosaccharides obtained from LMW (Panel A) and 
HMW (Panel B) glycopeptides that were bound to the E-PHA column. The doublets 
observed in Panel B are due to Na+ and ET forms being in almost equimolar amount.
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Figure 28: FAB-MS profiles o f the LMW (Panel A) and HMW (Panel B) that did not bind 
to the E-PHA column.
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indicated that not all of these glycans were selectively removed from the mixture. However 
a substantial depletion of these glycans in the unbound fractions was definitely achieved. 
Unfortunately during the isolation process the LMW E-PHA" fraction was contaminated by 
bacteria and could therefore not be used in the NK cell assays. Figure 29 shows the 
structures o f the glycans associated with the E-PHA+ HMW and LMW glycopeptides. 
Structural Identities o f the HMW and LM W  Glycopeptides
Glycopeptides used in this study were isolated after trypsin treatment of 
ovomucoid. The glycopeptides obtained after this treatment were separated into two peaks 
according to their size on a BioGel P4 column. It was reasoned that the glycopeptides in 
the LMW fraction primarily should consist of GP-1 based on their molecular weight as 
shown in Figure 20. The HMW fraction should be mainly composed of GP-2 and GP-3 
(Figure 20). This distribution of the glycopeptides was confirmed by biophysical analysis of 
the peptide sequences obtained after N-glycanase treatment (data not shown).
It is very likely that the E-PHA" HMW glycopeptides primarily composed of GP-2 
and not GP-3. This reasoning is based on the following arguments. GP-3 carries two 
glycosylation sites. Therefore presence of biantennary or triantennary bisecting type glycan 
at even one o f these two sites should be sufficient for GP-3 to bind to the E-PHA column. 
If GP-3 bound to E-PHA column via one of its glycans, it is very likely that glycans present 
on the other glycosylation site of this glycopeptide would be tetraantennary or 
pentaantennary glycans (Table 5). However, FAB-MS analysis of the E-PHA+ glycans did 
not indicate the molecular ions for such tetraantennary or pentaantennary glycans (Figure






























Figure 29: Structures of the glycans associated with the HMW and LMW glycopeptides 
that were bound to the E-PHA column.
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27 and 28). Unfortunately, due to lack of sufficient material, peptide analysis of this 
fraction could not be performed.
The elution profile of the E-PHA+ HMW glycopeptides on the RCAno column 
however, also indicates that GP-3 is not present in this fraction (Figure 30). The 
tetraantennary and pentaantennary glycans terminated with 4 and 5 Gal residues are 
expected to bind tightly to the RCA120 column, eluting off only in the presence of 0.1 M 
lactose. The elution profile of the E-PHA+ HMW glycopeptides on the RCA120 column 
shows three peaks (Figure 30). Peak 3 which was the most retarded is consistent with a 
triantennary trisgalactosylated oligosaccharide. Peak 2 is consistent with an oligosaccharide 
bearing two Gal terminals, which can be present on a triantennary bisgalactosylated or a 
biantennary bisgalactosylated oligosaccharide (Figure 30). Peak 1 can be obtained from a 
biantennary monogalactosylated oligosaccharide. These results are consistent with the 
FAB-MS analysis of the glycans present in the E-PHA+ HMW fraction. No radioactivity 
was eluted upon washing the column with 0.1 M lactose indicating that the tetraantennary 
or the pentaantennary glycans were not present in this fraction (Figure 30).
If GP-3 was present in this fraction at least a small amount of the tetraantennary or 
pentaanntennary glycans should have eluted in the 0.1 M lactose wash. However, no 
radioactivity was eluted in the 0.1 M lactose wash (Figure 30). Therefore the FAB-MS 
analysis taken together with the RCA120 affinity chromatography results clearly indicate that 
the E-PHA+ HMW fraction is mainly composed of GP-2.
FAB-MS analysis of the E-PHA' HMW fractions indicated the presence of both the 
triantennary and biantennary bisecting type glycans. Since GP-3 did not bind to the E-PHA
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Figure 30: Separation o f HMW E-PHA bound glycopeptides on a column o f immobilized 
RCA120. The glycopeptides were applied to a column (1 X 50 cm) of lectin-agarose (1 mg 
lectin/ml gel). Labeled oligosaccharides with 1, 2, and 3 Gal terminals eluted at the same 
numbered positions indicated by arrows. Specific elution with 0.1 M  lactose was 
performed to remove all bound glycopeptides.
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column it should all have been selectively eluted in the flow through fraction. A  significant 
percentage of the glycans present on both the glycosylation sites of this glycopeptide 
should bear triantennary and biantennary bisecting type glycans. Both the glycosylation 
sites are separated by only five amino acid residues. Such close spatial arrangement of the 
glycans probably results in a peculiar conformational orientation of both the glycan chains 
in solution. Due to such a configuration it is possible that E-PHA is not able to recognize 
the triantennary or biantennary glycans present on either one of these two glycosylation 
sites. The GP-3 glycopeptide therefore remain unbound and is found predominantly in the 
E-PHA" HMW fraction
Inhibition o f NK Cell And Lymphokine Activated Killer Cell Cytotoxicity By 
Glycopeptides
It has been reported earlier that culturing the isolated peripheral blood NK cells 
with IL-2 (interleukin-2) results in their activation. These activated cells are referred to as 
the lymphokine activated killers (LAK). In this study we have determined the effect of the 
E-PHA+ and the E-PHA" glycopeptides on both NK and LAK cell functions. The general 
experimental paradigm used for these in vitro assays is shown in Figure 20.
E-PHA + HMW Glycopeptides Inhibit NK and LAK Function
In the first experiment, the NK cells were cultured with the different glycopeptides 
(50 (iM final concentration of each glycopeptide) for 48 hr in the presence or absence of 
IL-2. Trypan blue assays conducted on the cells after the 48 hr incubation period indicated 
that more 90 % of the cells were viable. The labeled K562 target cells were then co­
cultured with the effectors (NK and LAK) at a effector: target ratio of 50:1 for the NK
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cells and 24:1 for the LAK cells.
The results obtained indicated that the E-PHA+ HMW significantly inhibited NK 
and LAK cell function (Figure 31). Marginal inhibition was observed when the effector 
cells were co-cultured with E-PHA" LMW glycopeptides (Figure 31). E-PHA' HMW 
glycopeptides exhibited virtually no effect on the NK and LAK cell function.
Concentration Dependent Inhibition o f LAK Activity by E-PHA* HM W  Glycopeptides
Having established that the E-PHA" HMW glycopeptides suppressed NK and LAK 
cell cytolytic responses it was necessary to determine the concentration dependence of this 
inhibitory effect at different effector cell: target cell ratios. However, as mentioned before 
only a small amount (1.5 mg) of the E-PHA" HMW glycopeptide could be isolated. Not 
enough material was available to perform experiments with both the NK and LAK cells. 
We therefore focused on obtaining data using LAK cells. The LAK’s were cultured for 48 
hr with 20, 10, 5, and 1 pM final concentration of the E-PHA" HMW glycopeptide. Assays 
were performed at effector celhtarget cell ratios of 24:1, 12:1, 6:1, and 3:1. The data 
obtained clearly showed a concentration dependent inhibition of the LAK responses by the 
E-PHA" HMW glycopeptides (Figure 32). These results suggest that 50% inhibition of the 
LAK cytolysis can be achieved between 5 pM and 10 pM concentration of the E-PHA" 
HMW glycopeptides (Figure 32).
E-PHA* HMW Glycopeptides Inhibit The Activation Events O f LAK Cells
In all of the experiments mentioned above, the LAK or NK cells were cultured with 
the glycopeptides for 48 hr prior to incubation with the target cells. The next experiment
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Figure 31: Inhibition ofNK and LAK responses at maximal EC:TC ratios tested (50:1 for 
NK and 24:1 for LAK). The concentration of added glycopeptides was 50 jiM. Each assay 
was performed 6 times.
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Figure 32: Concentration dependence of the inhibitory effect of the HMW E-PHA bound 
glycopeptides on LAK cells at different EC:TC ratios. Each assay was repeated 6 times.
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was therefore designed to study the effect of the glycopeptides when added during the 4 hr 
cytolytic assay. The experimental paradigm used for this experiment is briefly shown in 
Figure 22. Assays were performed with LAK cells at effectontarget cell ratios of 12:1 and 
6:1. The effector and target cells were co-cultured for 4 hours in the presence of the E- 
PHA" HMW, E-PHA' HMW, and E-PHA" LMW glycopeptides at a final concentration of 
20 mM. In separate experiments, the LAK cells were also incubated with these 
glycopeptides for 48 h. The glycopeptides were removed by centrifuging the LAK’s and 
washing them twice with RPMI-10 media. The washed LAK cells were mixed with the 
target cells at effectontarget cell ratios of 12:1 and 6:1.
Glycopeptides tested had very little effect on the LAK responses when added 
during the 4 hr cytolytic assay (Figure 33). Washing of the LAK’s prior to performing the 
cytolytic assay had no significant effect on difference in the inhibition profiles of the 
glycopeptides (Figure 33). The E-PHA" HMW glycopeptides were again found to potently 
inhibit LAK mediated cytolysis under these conditions (Figure 33).
Ovomucoid and Conalbtimin Have No effect On NK Cell Mediated Cytolysis
As a control experiment we determined if incubation with either conalbumin or 
ovomucoid had any effect on NK cell function. These glycoproteins had no inhibitory effect 
on NK cell function at this concentration when incubated for 48 hr with the NK cells at 100 
|j.g/ml concentration (Figure 34). In fact there appeared to be a slight stimulatory effect 
with conalbumin (Figure 34). Another control experiment would have been to determine if 
galactosylated ovomucoid or conalbumin was capable of affecting NK cell function. 
However, incubation of 1 mg of each glycoprotein with 2 units of bovine milk
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Figure 33: Addition of the E-PHA+ HMW glycopeptides during the 4 h cytolytic assay 
does not result in inhibition of NK cell function. For 4 h comparison points, NK cells were 
stimulated with EL-2 for 48 h. Target cells were added to obtain the appropriate EC-TC 
ratio along with glycopeptides at a final concentration of 20 pM for the assay. In the 
+Wash comparisons, NK cells were incubated with IL-2 for 48 h with glycopeptides. The 
cells were washed 2 times to remove glycopeptide and IL-2 and subjected to the cytolytic 
assay at the given target ratios. Each assay was performed in triplicates.
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Figure 34: Effect o f ovomucoid and conalbumin on NK cell cytotoxicity. This experiment 
was carried out in triplicate.
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galactosyltransferase, 3 mM UDP-Gal and 1 X 106 cpm of UDP-[3H]GaI under optimal 
conditions for galactosylation (Barker, et al., 1972) did not lead to any detectable 
galactosylation of either ovomucoid or conalbumin. Therefore the potential effect of 
galactosylated ovomucoid and conalbumin on NK cell activity could not be tested.
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DISCUSSION
Protection of the developing human from the maternal immune response is a vital 
function in reproduction (Hegde, 1991). Similarly, defending the human spermatozoa and 
eggs from potential immune responses would also be beneficial for the propagation of the 
species. As described in Chapter HI, we have recently proposed the Hu-FEDS hypothesis 
which states that specific glycoconjugates expressed during pregnancy and on the surface 
of the male and the female gametes are responsible in suppressing the female’s immune 
responses thereby allowing fertilization and implantation to occur. In the current study we 
provide preliminary evidence that specific glycans can inhibit immune cell function.
Only E-PHA+ HMW Glycopeptides Inhibit NK/LAK Cell Function
The NK and LAK cell assays indicated that the E-PHA" HMW glycopeptides were 
potent inhibitors of cytolytic responses. These results indicated that either the biantennary 
or triantennary bisecting type glycans or both were able to inhibit NK or LAK activities. 
The E-PHA' HMW fractions which contained a mixture of the tetraantennary and 
pentaantennary glycans in addition to triantennary and biantennary bisecting type glycans 
did not have any effect on NK or LAK cell mediated cytolytic responses. As mentioned 
before, the triantennary and the biantennary bisecting type glycans detected in the E-PHA' 
HMW fraction are probably present on the GP-3 glycopeptide. The close proximity of the 
two glycosylation sites present in this glycopeptide probably results in these glycans not 
being recognized by E-PHA. It is likely that due to similar reasons, the triantennary and 
biantennary glycans present on GP-3 are unable to interact with the inhibitory cell surface
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receptors expressed on the NK or LAK cells. Therefore, although the triantennary or 
biantennary bisecting type glycans are present the E-PHA" HMW fraction is not capable of 
inhibiting NK or LAK cell mediated cytolytic responses. The inability of the E-PHA- HMW 
glycopeptides to suppress NK or LAK cell activities also strongly suggests that the 
tetraantennary or pentaantennary bisecting type glycans present in this fraction are not 
inhibitory.
Another interesting observation made in these studies was that although the E- 
PHA+ LMW fraction contained the triantennary and biantennary bisecting type glycans, 
these glycopeptides were not as potent in inhibiting the NK or LAK cell responses as the E- 
PHA+ HMW glycopeptides. The oligosaccharides of the LMW glycopeptides are carried on 
a 7 amino acid peptide, the E-PHA+ HMW glycans are presented on a 32 amino acid 
peptide sequence. It is therefore likely that the inhibitory receptors present on the NK or 
LAK cells recognize the bisecting type glycans in the context o f their peptide sequences. 
Presentation of these glycans on a longer rather than short peptide sequence results in a 
better recognition of the glycans by these receptors leading to a more potent inhibition of 
NK or LAK cell function.
The results presented in this study therefore indicate that the inhibitory receptors 
expressed on the NK or LAK cells have a strict specificity for the triantennary or 
biantennary bisecting type glycans. These receptors are not affected by the tetraantennary 
or pentaantennary bisecting type glycans. Furthermore, it is also likely that presentation of 
the inhibitory glycans on an appropriate peptide platform may be absolutely essential for 
potently abrogating the NK or LAK cell responses. Further studies are absolutely required 
for clearly characterizing the details of the inhibitory effects exhibited by these
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glycopeptides.
It is likely that glycoconjugates expressing the bisecting type may play an important 
role in inhibiting the maternal immune responses. During pregnancy, 2-3 weeks prior to 
term, a clinical development known as cervical ripening is observed (Romero, 1994). This 
process is accompanied by a substantial influx of inflammatory cell types into the cervix and 
decidua, the cause of this influx is not known. It is however interesting to note that this 
recruitment of the immune effector cells correlates temporally to the loss of Gd-A synthesis 
and also the changes in the glycosylation pattern of AFP. It is therefore also possible that 
removal of these suppressive factors plays a role during child birth. It would therefore be 
significant to study if an untimely removal of such glycoconjugates during pregnancy could 
lead to premature labor in some clinical cases.
Expression o f the Bisecting Type Sequences on HIV
There is evidence indicating that the human immunodeficiency virus (HIV) may also 
be acquiring the biantennary bisecting type glycans. Infection of human H9 lymphoblastoid 
cells with HIV yields the viral glycoprotein gpl20. Analysis o f the V-linked glycans 
associated with this form of gpl20 indicates that approximately 11% of the glycans carry 
the bisecting type biantennary glycans (Mizouchi et al., 1990). It would be interesting to 
study if the expression of this glycan sequence helps the virus to evade NIC cell mediated 
responses.
Glycosylation o f HIV Glycoproteins
The gpl20 glycoprotein is a heavily glycosylated protein with up to 20 total N- 
linked and an undetermined number of (9-linked glycosylation sites. Thus a vast diversity of
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oligosaccharide sequences can be expressed on this glycoprotein. A significant question 
that can be asked here is does the expression of such diverse glycans help HEV to induce 
immunosuppressive effects in the human? We have recently proposed a model that could 
possibly explain role of glycoconjugates expressed on the HIV glycoproteins in mediating 
the potent immunosuppressive effects observed in infected individuals.
HIV is unique because of its ability to preferentially infect the T-lymphocytes 
(Barre-Sinoussi et al., 1983). The virus therefore has an uncontrolled access to the 
glycosylation machinery of the T-cells. HTV glycoproteins could therefore acquire glycan 
sequences that may be exclusive to the T-cell glycoproteins. A growing number of 
receptors expressed on the immune cells have been shown be lectins. Some of these lectin 
receptors like the selectins bind only to the carbohydrate ligands (Varki, 1994)whereas 
others like CD22 recognize the carbohydrates in the context of the protein structures to 
which the glycans are attached (Hanasaki et al., 1994; Powell and Varki, 1994).
Thus after infection, the HIV glycoproteins could acquire the oligosaccharide 
sequences that are usually found on the T-cell glycoproteins. Expression of such 
oligosaccharides could therefore enable the virus to inhibit or evoke a particular immune or 
inflammatory response via lectin receptors that only require recognition of the 
carbohydrate. Several reports also indicate that the HTV proteins share significant structural 
similarities with some of the T-cell proteins (Golding et al., 1988; 1989; Imberti et al., 
1991; Dalgleish et al., 1992; Levy, 1993). Glycosylation of such HTV proteins in the T-cell 
could therefore also result in their recognition by receptors that require both the 
carbohydrate and the protein structures together.
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Such molecular mimicry could be extremely important for HIV virus during the 
initial stages of infection when the major goal for the virus is establish itself in the T-cells. 
Because of its high rate of mutation, infected T-cells could produce mutant viruses that 
could either be destroyed or propagate depending on their ability to infect other cells and 
evade or misdirect the immune response. The high mutational rate in the viral genome 
coupled with the selective pressures applied by the host’s immune system could therefore 
lead to the production of mutant virions that could completely defeat the host’s immune 
system.
Our hypothesis therefore predicts that by acquiring the T-cell glycans at least a 
fraction of the HIV infected cells that closely mimic the T-cell glycoproteins could evade 
immune responses directed against them. The viruses that survive the immune attacks could 
then be able to utilize their glycans to interact with the carbohydrate receptors of other 
cells, enabling them to infect a variety of different immune and non-immune cell types. 
Finally, soluble or cell surface associated viral glycoproteins carrying the appropriate chains 
could inhibit normal immune function or induce aberrant immune responses. These 
mechanisms could eventually lead to the generation of a variant set of viruses that could 
overwhelm the immune system, leading to the development of the acquired 
immunodeficiency syndrome (AIDS).
Glycoconjugate Mediated Recognition o f Self
Finally the results obtained in our experiments with the NK and LAK cells have 
clearly indicated that the bisecting type biantennary or triantennary glycans can inhibit their 
cellular responses. However, the exact mechanisms by which these glycopeptides are able 
to abrogate the NK or LAK cell activities are not known at this point. However, as
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mentioned earlier, many different KIR and KAR expressed on the surfaces o f the NK cells 
carry C-type lectin domains (Moretta, et al., 1997). It is possible that the some KIR may 
bind to the bisecting type glycans thereby triggering a signaling cascade that results in the 
inhibition of NK cell function. As mentioned earlier, NK cells recognize the absence of 
MHC molecules on the surface of their target cells (Moretta, et al., 1992). However, we 
believe it is likely that the NK cells may also be looking for the expression of the 
appropriate glycoconjugates on the targets. The lack of expression of such glycoconjugates 
may result in induction of the cytolytic responses against the target cells. Therefore, the 
expression of these appropriate glycoconjugates may in turn be a signal to the NK or LAK 
cells to recognize the target cell as self. It would be interesting to study if specific 
glycoconjugates could also suppress responses mediated by other immune cell types. If so, 
recognition of self could be mediated not only by the MHC system but also by the 
expression of cell surface associated glycoconjugates.
Conclusion
In this chapter we have provided preliminary evidence suggesting that specific 
exposure of the NK or LAK cells to specific glycoconjugates could inhibit their cellular 
responses. More work will definitely be needed to characterize the exact mechanism 
involved in mediating such glycoconjugate mediated suppressive effects. However the 
occurrence of the bisecting type glycans on glycoproteins like AFP and on HTV gpl20 
strongly suggests that suppression of cellular immunity by glycoconjugates may be playing 
a significant physiological role in pregnancy and also in various pathological states. These 
preliminary studies may lead to new approaches for understanding the human immune and 
reproductive systems and may help in providing better avenues to combat infections.




Many previous reports have suggested that glycoconjugates could play important 
roles in human gamete binding interactions and also in various immune cell functions 
(Gahmberg et al., 1992). Substantial evidence obtained in the mouse system clearly 
indicates that the oligosaccharides expressed on the surface of the ZP are absolutely 
essential for mediating sperm binding (Wassarman, 1990). Unambiguous evidence for the 
involvement of the human ZP oligosaccharides in mediating gamete adhesion however has 
not been available so far. The experiments conducted in this study strongly support such a 
role for the ZP oligosaccharides. We have performed carefully controlled studies to 
demonstrate that glycoconjugates or oligosaccharides bearing restricted structures are able 
to potently block human sperm-ZP binding in an in vitro assay system. Such a specificity 
for the oligosaccharide structure clearly indicates that the egg binding protein expressed on 
the surface of the sperm is recognizing a oligosaccharide ligand present on the ZP. Using 
subtle chemical and enzymatic modification that affect only the ZP oligosaccharides, we 
have shown that sperm binding to these treated ZP can be significantly affected. Periodate 
treatment of the ZP under mild conditions that affect only the terminal sialic acid residues 
results in approximately 30% inhibition of sperm binding. Similarly periodate oxidation of 
the ZP under conditions that affects all of the terminal sugars, results in a significant 40% 
inhibition of sperm binding. Both these experiments indicate that chemical modifications of 
the terminal ZP oligosaccharides substantially affects human sperm-ZP binding. We have
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also shown that removal of the terminal sialic acids and also some of the terminal 
polylactosamine chains significantly increases sperm binding to the ZP indicating that the 
egg binding receptor present on the human sperm may be recognizing some internal 
oligosaccharide motifs. Removal of the outer glycans helps the receptor to better recognize 
the internal oligosaccharides.
Periodate oxidation experiments conducted on neuraminidase treated ZP perhaps 
provide the most compelling evidence supporting the role of the ZP oligosaccharides in 
mediating sperm binding. Mild periodate treatment of neuraminidase treated ZP results in a 
almost complete loss of sperm binding. It is likely that the removal of the terminal sialic 
acids results in complete exposure of the internal glycan residues. However treatment of 
these residues with periodate results in their total chemical modifications which are not 
recognized by the egg binding protein present on the sperm.
Collectively all of this data unambiguously demonstrates the role of the ZP 
oligosaccharides in mediating initial human sperm-egg binding. We are pursuing different 
approaches to clearly identify the glycan structures that are required to mediate this 
adhesion event. Identification of such glycan sequences would greatly help in identification 
of the egg binding protein expressed on human sperm. A better understanding of these 
processes would lead to the development of novel contraceptives and also in the devising 
better strategies for treatment of at least some causes of infertility.
Finally our studies have also indicated that a considerable overlap likely exists 
between the carbohydrate ligands involved in human gamete binding and in the mediating 
various immune cell functions. On this basis we have proposed that specific expression of 
immunosuppressive glycoconjugates occurs during pregnancy. Such temporal expression of
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these glycoconjugates may be absolutely required to protect the human embryo/fetus from 
the maternal immune responses. This paradigm is referred to as the Human fetoembryonic 
defense system hypothesis (Hu-FEDS). It is proposed that the human gametes and other 
glycoconjugates expressed during pregnancy specifically acquire glycans that potently 
suppress the cell mediated cytolytic responses of the maternal immune system. The first 
preliminary evidence for the existence of such a glycoconjugate based immunosuppressive 
system is provided in this study. First we show that the human gametes express the 
bisecting type GlcNAc sequences which have been previously suggested to inhibit NK cell 
mediated responses. In chapter IV we have synthesized and isolated the bisecting type 
glycopeptides and shown that they can potently inhibit NK cell mediated cytolysis of the 
target K562 cells.
AFT* and other glycoproteins expressed during pregnancy have been previously 
shown to carry the bisecting type glycans (Tsuchida, et al., 1984). We therefore believe 
that specific expression of such glycans on these glycoproteins may play an important role 
in the immunoprotection of the embryo/fetus. In addition many different studies have 
indicated that the expression of the bisecting type and other unusual glycans on the surfaces 
of parasites (Mizouchi et al., 1990; Kang, et al., 1993). Expression of the bisecting type 
glycans has also been demonstrated on the HIV glycoprotein gpl20. It may therefore be 
very likely that these different pathogens may be co-opting the same glycoconjugate based 
system of immunosuppression that is used to protect the fetus to evade the hosts immune 
responses. Further studies are currently in progress to determine the exact mechanisms by 
which these glycopeptides inhibit the NK cell responses. However, the data obtained from 
these studies may have paved a way for developing new strategies to understanding
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fetomatemal tolerance and the ability of different pathogens to circumvent the immune 
response of the host.
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